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1. Concordance between self-reported and GP-reported treated
asthma in Wales
Al Sallakh MA, Rodgers SE, Lyons RA, Sheikh A, Davies GA
Swansea University Medical School, UK
Aim: Analysis of concordance between case identiﬁcation criteria helps
judge their reliability. We analysed the agreement between GP-reported
data-driven and self-report case identiﬁcation of current treated asthma
(CTA) in Wales.
Method: We accessed a subset from the Welsh Health Survey (WHS) 2014
results including 6,702 individuals aged 15+. We excluded those with invalid
CTA responses or whose records could not be linked to the GP dataset in
the Secure Anonymised Information Linkage Databank. From the GP
dataset, we used observed variables about asthma diagnosis and
prescriptions to perform latent class analysis (LCA). In the best ﬁtting
model, latent classes consistent with CTA were combined into a
”GP-reported CTA” group. We then estimated the concordance between
self-reported CTA from the WHS and both GP-reported CTA and ever-
diagnosed-or-treated asthma.
Results: We included 4,187 people, of whom 439 (10.5%) had self-reported
CTA but of these 13% had no recorded asthma diagnosis or prescriptions in
the GP data. The best ﬁtting LCA model contained 7 classes; 5 classes
including 346 people (8.2%) were consistent with CTA. The share
of ever-diagnosed-or-treated asthma was 16.1%. Only 246 (5.9%) people
had both self-reported and GP-reported CTA; Cohen's kappa for agreement
between the two classiﬁcations was 0.59. This increased to 0.62 when self-
reported CTA was compared with GP-reported ever-diagnosed-or-treated
asthma.
Conclusion: Self-reported current treated asthma has only moderate
to good agreement with both GP-reported treated asthma and ever-
diagnosed-or-treated asthma. This could be explained by over-self-
reporting and/or under-reporting of diagnosis and prescriptions
by GPs.
Conﬂicts of interest: None.
Funding: Health and Care Research Wales and Abertawe Bro Morgannwg
University Health Board. Supported by Asthma UK Centre for Applied
Research [AUK-AC-2012-01] and The Farr Institute@CIPHER (MRC Grant
No: MR/K006525/1).
Corresponding author: Mohammed Al Sallakh
Email address: m.a.al-sallakh.594803@swansea.ac.uk
2. Use of blood eosinophil count to predict inhaled steroid
responsiveness in patients with COPD using UK primary care
health records
Ashdown HF, McFadden E, Smith M, Thomas DM, Pavord ID,
Bafadhel M, Butler CC
University of Oxford, UK
Aim: This study aims to evaluate whether initiating inhaled corticosteroid (ICS)
treatment in patients with COPD is more effective in those who have higher
levels of pre-treatment blood eosinophils compared to those with lower levels
of blood eosinophils.
Method: This is a cohort study using the Clinical Practice Research Datalink
(CPRD) which collects routine data from UK primary care, linked with Hospital
Episode Statistics (HES) data. Inclusion criteria will be patients with a diagnosis
code for COPD and spirometry diagnosis, aged ≥ 40 years with smoking
history, who are not already treated with ICS (ICS-naïve), starting a new inhaled
maintenance medication for COPD (intervention group: ICS; comparison
group: long-acting bronchodilator).
A descriptive component will examine routine blood eosinophil testing in
primary care and stability over time. The hypothesis-testing component will
test whether baseline blood eosinophils predict disease outcomes, and
outcomes under treatment (ICS responsiveness). The primary outcome will be
acute exacerbations of COPD. Disease outcomes over time will be compared
between intervention and comparison group, with adjustment for baseline
characteristics, and this will be stratiﬁed by baseline blood eosinophil values to
determine whether this modiﬁes effectiveness of treatment.
Results: We have obtained relevant ethical approvals and data management
will commence shortly. Further discussion of the planned project and any
preliminary results will be presented.
Conclusion: Characterising blood eosinophils in the primary care COPD
population and their role in predicting disease outcomes under ICS treatment
may enable eosinophil-guided ICS treatment in future.
Conﬂicts of interest: None.
Funding: National Institute for Health Research.
Corresponding author: Helen Ashdown
Email address: helen.ashdown@phc.ox.ac.uk
3. Clinical characteristics of pertussis-associated cough: a
diagnostic accuracy systematic review
Ashdown HF, Moore A, Shinkins B, Harnden A
University of Oxford, UK
Aim: Bordetella pertussis (whooping cough) is an important cause of persistent
cough in patients presenting to primary care, but presentation is not always
classical, and can be along a clinical severity spectrum from minor cough to
repeated severe paroxysms. This systematic review aimed to determine the
diagnostic accuracy of different clinical features of pertussis.
www.nature.com/npjpcrm
Published in partnership with Primary Care Respiratory Society UK
Method: Searches were conducted in CINAHL, Embase, Medline and Science
Citation Index, including conference proceedings. Studies from any health care
setting were included if they compared clinical features in patients with
laboratory-conﬁrmed pertussis against those without. Study authors were
contacted for clariﬁcation and/or additional data if needed. Quality of included
papers was assessed using the QUADAS-2 framework. The index tests were
clinical features of pertussis, and the reference test was conﬁrmed pertussis
diagnosis.
Results: 3993 papers were identiﬁed through the initial database search, of
which 331 were selected for full text review. Of these, 49 met the criteria for
study inclusion, from which data has been extracted. A variety of history,
examination and basic investigations potentially associated with pertussis
have been assessed. Meta-analysis of results and an updated search is currently
underway. A diagnostic scoring system based on different clinical features will
be created if possible.
Conclusion: This systematic review will draw together ﬁndings from many
observational studies, to provide a greater understanding of characteristics of
pertussis cough and other associated clinical features. This could help primary
care clinicians to differentiate cough due to pertussis from other causes of
persistent cough, which could help prevent unnecessary investigations and
offer patients a more accurate cough prognosis.
Conﬂicts of interest: None.
Funding: None.
Corresponding author: Helen Ashdown
Email address: helen.ashdown@phc.ox.ac.uk
4. Lung health screening in male construction workers
Astles CM, Lippiett KA, Gillett K, Rigge L
University Hospitals Southampton, England
Brief outline of context: To identify those at risk and raise awareness of lung
disease in men working in construction.
Outline of problem: Men who work are less likely to seek advice about disease
conditions or symptoms. Construction workplace exposures are likely to
contribute to COPD. Smoking remains the key risk factor; prevalence amongst
Southampton's manual working group is high at 32.3%.
Assessment: World COPD Day provides an opportunity to raise the proﬁle of
Respiratory health and COPD to an at risk group seldom seen in primary care.
Strategy: A multidisciplinary team with research and clinical backgrounds
approached construction companies on site at Southampton Hospital to
release employees to attend a pop-up lung screening clinic.
Effects of changes: Intervention required in over half of attendees (see Tables 1
and 2).
Lessons learnt: Workers cited peer encouragement and clinic accessibility
(permission, proximity, paid work time) as integral to attendance. The
managers reported a number of current smokers declined to attend.
Respiratory awareness days are an opportunity to target high risk seldom
heard groups.
Conﬂict of interest: None.
Funding: National Institute for Health Research Collaboration and leadership in
applied research and care Wessex and Southampton Integrated COPD Team.
Corresponding author: Carla Astles
Email address: carla.astles@nhs.net
5. What is the association between Chronic Obstructive
Pulmonary Disease (COPD) and health-related quality of life in
Manchester in 2011?
Beaumont-Kellner H, Frank T, Caress A
University of Manchester, UK
Aim: This study examines the association between COPD and health- related
quality of life (HRQoL) in Manchester in 2011 using a generic health- related
quality of life questionnaire and was part of a Masters in Clinical Research. The
study formed part of a larger primary care study, which covered 20 general
practices in Greater Manchester. This number of practices will yield a large
volume of responses; therefore, a smaller sub group of COPD and comparator
patients from six practices is used for this MClin Res project. It is evident in the
literature that there is no recent information on this group of patients in the
UK. Confounding variables such as age, socioeconomic status, demographics
and co-morbidity in this sample are also discussed.
Method: This quantitative cross-sectional questionnaire comparator study
collected data from six practices using the EQ-5D and EQ-5Dvas from a
primary care patient population with COPD and co-morbidity. Patients were
identiﬁed from the practice QOF registers using Apollo Medical software
(read codes are supplied to Apollo Medical and anonymous data is extracted
and matched up with the completed patient questionnaire) or manually by
the author.
A 5% randomly selected of patients aged 16 years and over without a chronic
condition were included in the comparator group. An alert was put on each
patient record to assist GPs and nurses at the practice to avoid opportunistic
comparator group sampling. HRQoL was measured and analysed alongside
demographic information, which was supplied by the patient. Data was
collected over a 6-month period.
Results: Statistical analysis was used to test the null hypothesis of no
association between HRQoL and COPD, using the Chi-squared test for
association and Fishers Exact on categorical ordinal data. To look for a
difference between the two groups the Mann-Whitney U test and Wilcoxon
test were used due to the non-normal distribution of the data (Machin et al.,
2007).
A total of 88 patients with COPD or in the comparator group were selected
from the total sample (n= 1000). Current or ex-smokers were more likely to
have COPD (P= 0.0001). Patients with COPD reported a lower ‘health state’
score compared to the comparator group using the EQ-5Dvas (P= 0.007). In
addition there was a signiﬁcant association between further or higher
education after the age of 16 years and COPD (P= 0.0008).
Conclusion: This study contributes to current literature, by supporting and
validating previous arguments. COPD patients in Manchester had a lower
health state compared to the comparator group, and responders with COPD
were more likely to smoke and did not complete further education over the
age of 16 years. These results emphasize the importance of individual patient
experience, their perceived health state and the need to continually improve
disease management by applying HRQoL measurements. However, limitations
of the study results include the small sample size and confounding variables
such as age.
Table 1Measurement of improvement.
* 18 men voluntarily attended with a mean age of 43
* 8/18 ex-smokers
* 4/18 current smokers
* 2/18 FEV1/FVC o 70% predicted; 1 asthmatic, 1 with symptoms suggesting COPD
* 3/18 known asthmatics; 100% with poor control
* 2/18 symptoms suggesting other respiratory diseases
* 1/18 anxiety symptoms
Referral to primary care provider:
* 3/18 poor asthma control
* 1/18 conﬁrmation of COPD diagnosis
* 2/18 further investigation of respiratory symptoms
Other interventions:
* 4/4 smokers requested smoking cessation advice
* 1/18 referred to talking therapies
Abstracts
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Conﬂicts of interest: None.
Funding: This project was supported by the Greater Manchester Clinical
Research Network.
Corresponding author: Helen Beaumont-Kellner
Email address: chicabroad@yahoo.com
6. Stepping down high dose steroids in asthma patients using
(smoking, inhaler technique, monitoring, pharmacotherapy,
lifestyle, education, support) SIMPLES approach
Canavan M
Practice Nurse, Leeds, UK
Outline: The British Thoracic Society BTS/SIGN guideline on the management
of asthma recommends that reductions in inhaled corticosteroid (ICS) dose
should be considered every 3 months. The guideline states that stepping
down therapy once asthma is controlled is recommended but is often not
implemented, leaving some people over treated.
Outline of problem: Combination therapy with anICS and an addition of a long-
acting beta2 agonist (LABA) is the preferred treatment at step 3, when the use
of an ICS alone is insufﬁcient for the control of persistent asthma. However
research has found that when initiating a combined inhaler this has resulted in
widespread increase in ICS dose.
Assessment: Our practice is situated in a deprived area, asthma prevalence is
currently 6.3% and the national prevalence is 6.0%. The national prevalence for
COPD is 1.7% our practice is 3.9%. We also have high prevalence for mental
health and smoking rates that have an impact on asthma management.
Strategy: We ran reports to identify asthma patients on high dose steroids and
called them in for a review. The SIMPLES approach (smoking, inhaler
technique, monitoring, pharmacotherapy, lifestyle, education, support; Ryan
et al., 2013) was used to review these patients and step them down.
Measurement of improvement: Every quarter the practice receives an MOT
report from the Clinical Commissioning Group (CCG), with prescribing costs,
smoking cessation rates and hospital admissions. Every week we run a report
to see who has attended A&E and we have not increased our admission rates
for asthma.
Effects of changes: Our respiratory prescribing costs have dramatically reduced
since 2012/2013 from £123,818 to £74,816 in 2014/2015 saving £49,002 most
practices in the CCG also made respiratory savings with an average saving of
£13,811. These savings do also include stepping down steroids in COPD as per
previous poster. But the reduction of high dose steroids reduces costs and also
reduces side effects leading to improved quality of life.
Lessons learnt: Most symptomatic asthma patients do not need high dose
steroids, other factors need addressing such as inhaler technique and
co-morbidities in the ﬁrst instance before increasing inhaled therapy.
Message for others: Reviewing patients using the SIMPLES approach has helped
to reduce the steroid dose for asthma patients, but can also be used during
routine appointments to prevent over treatment.
Conﬂict of interest: None.
Corresponding author: Melissa Canavan
Email address: m.canavan@nhs.net
7. Admission Avoidance for COPD patients: a Specialist Nurse
approach
COX K1, MACLEOD SC1, SIM CJ1, JONES AW2, TRUEMAN, J1
1Lincolnshire Community Health Services NHS trust, Lincoln, UK.
2Lincoln Institute for Health, University of Lincoln, Lincoln, UK.
Abstract
Aim: To evaluate the safety and effectiveness of a specialist nurse-led Acute
Respiratory Assessment Service (ARAS) for COPD patients.
Background:: COPD is the second highest cause of emergency admissions of
any chronic disease in the UK (DH, 2010). ARAS was developed with the aim to
provide a safe, effective model of care and reduce unnecessary hospital
admissions.
Design: A retrospective case-note audit of patients referred to ARAS over a 12
month period from April 1st 2014–March 31st 2015.
Methods: Data was collected and analysed for: length of time patients received
the service, number and type of contacts, treatment prescribed and mortality
and admission rates due to respiratory reasons and all causes.
Results: One hundred and twenty eight patients (Mean7standard deviation;
age 74.2711.0 years) with conﬁrmed COPD were referred and received care
for 16.078.8 days. Number of visits and telephone reviews was 3.571.4 and
1.571.4 respectively. Ten patients (7.8%) were admitted to hospital due to all
causes with six (4.6%) of these being respiratory reasons. Mortality rate was nil.
Conclusion: An ARAS service led by Respiratory Nurse Specialists skilled
and competent in prescribing and reassessing specialist interventions
(e.g. nebulised therapy and emergency oxygen therapy), is a safe and
effective model for treating COPD patients at home. This service reduces the
number of patients presenting to emergency departments and being
admitted to hospital. This has important economic beneﬁts to healthcare
whilst also having beneﬁcial effects on patient experience and satisfaction.
Conﬂicts of interest: No conﬂict of interest has been declared by the author(s).
Corresponding author: Karen Cox
Email address: richardandkarencox@gmail.com
8. Feedback from chronic respiratory disease education on
community-based nurses in Dorset
McConnell WD, Ennor C, Freer M
Dorset County Hospital NHS Foundation Trust, UK
Brief outline of context: A competency-based, multiprofessional educational
course was delivered to improve the skills of community nurses about the
broad range of chronic respiratory disease. The feedback from six courses was
evaluated, exploring their value and improvement options.
Outline of problem: Training for staff in the community about respiratory
disease is needed to increase staff conﬁdence and reduce the burden on
secondary care.
Assessment: Whilst training in asthma and COPD management is generally
available, training on the assessment of the breathless patient and the
management of the rarer lung diseases is less established.
Strategy: A 3-day multiprofessional education programme covering COPD,
bronchiectasis (BE), interstitial lung disease (ILD) and the assessment of the
breathless patient was delivered, supported by a portfolio of ongoing learning,
aimed primarily at community nurses.
Measurement of improvement: Written feedback from 72 of the 77 delegates on
the 6 courses over 2 years, assessing the areas that are most valued by them.
Effects of changes: The feedback was overwhelmingly positive. The most
valued sessions covered BE, ILD, end of life care, inhalers, pulmonary
rehabilitation, respiratory history taking and the breathless patient. Case
studies and the delivery of the training by local respiratory consultants were
appreciated.
The need for such a course was conﬁrmed. Other elements desired were
asthma management, spirometry, oxygen care and a need to strengthen
ongoing mentorship for community staff. There is an enthusiasm for
respiratory training in the community beyond the traditional areas of asthma
and COPD.
Conﬂict of interest: None.
Funding: The programme was a collaboration between the National
Health Services and J2S, supported by funding from Dorset Clinical
Commissioning Group, GlaxoSmithKline, Pﬁzer, AstraZeneca, Boehringer
Ingelheim, Chiesi, Teva.
Corresponding author: Christine Ennor
Email address: christineennor@hotmail.com
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9. "Breathless not helpless”: developing a community
respiratory service for people with COPD
Fagan M, Guild R
National Health Services (NHS) Tayside, UK
Outline: An overview of a transformational change programme delivered in
Angus Community Health Partnership (CHP) over a 10 year period to develop
evidence based care for people living with COPD.
Outline of problem: Patients were often misdiagnosed as asthma and unlikely
to be diagnosed with COPD until relatively advanced. There was little in the
way of comprehensive review following diagnosis particularly for housebound
patients. Pulmonary rehabilitation was 20 miles away and was usually accessed
following an admission.
Assessment: There was limited access to diagnostic spirometry in community
with few GP practice staff having any specialist COPD knowledge. No access to
training locally - the nearest COPD and asthma diploma courses were
delivered 70 miles away.
Strategy: A respiratory working group was established and the following steps
milestones progressed: (1) Development of a local service model based on
clinical evidence, including: Diagnosis and COPD management in primary care,
Specialist nurses, Pulmonary rehabilitation, Housebound Service; (2) Peer
support groups established; (3) Long Term Oxygen Therapy pathway; (4)
Palliative care pathways; (5) Regular local COPD education and awareness
events.
Measurement of improvement: Hospital admission rates, bed days and average
length of stay were used as measures of improvement.
Effects of changes: This programme through its focus on collaboration with the
local COPD population has greatly increased equality of access to evidence
based care and has improved patient outcomes signiﬁcantly.
Despite a signiﬁcant increase in COPD prevalence, COPD related admissions,
bed days and average length of hospital stay are decreasing. Small tests of
change will show if something can be implemented easily and can lead to
greater sustainable changes.
Message for others: Collaborative working between primary and secondary care
and patient representatives can improve outcomes for people living
with COPD.
Conﬂict of interest: None.
Funding: Core funding from Angus Community Health Partnership.
Corresponding author: Maureen Fagan
Email address: maureen.fagan@nhs.net
10. Is the ‘blue’ colour convention for inhaled reliever
medications important? A UK based survey of healthcare
professionals and patients with airways disease
Fletcher M, Scullion J, White J, Thompson B, Capstick T
Education for Health, UK
Aim: In many countries, short-acting beta 2 agonist inhalers have traditionally
been coloured blue. This inhaled therapy has also conventionally been known
as a ‘reliever’ by patients and healthcare professionals (HCPs), in comparison
with ‘preventer’ medications (inhaled steroids). With the rapidly changing
market in inhaled therapy for COPD and asthma and growing numbers of
devices, there has been some concern that the erosion of traditional colour
conventions is leading to patients (and HCPs) becoming confused about the
role of different therapies.
Method: In order to assess whether there was concern over the perceived
changing colour conventions the UK Inhaler Group carried out a large online
survey of patients and HCPs to assess the perception of the importance of
inhaler colour and whether there was a requirement to formalise colour
schemes.
Results: The results of the survey highlighted the importance of the term ‘blue
inhaler’ for patients with only 11.3% never referring to the colour when
referring to their inhaler. For HCPs 95% felt colour conventions were important
when referring to reliever medication. Additionly, HCPs appear to refer to
inhalers mainly by colour when talking to patients.
Conclusion: Our conclusions were that concept of a ‘blue inhaler’ remains
important to tents and health care professionals. These results add to the
debate about the need to formalise the colour coding of inhaled therapies, in
particular using the colour blue for inhalers for rapid relief of symptoms, since
formalising this convention may be an important measure and contributor to
patient safety. Our survey should provide impetus for all interested parties to
discuss and agree a formal industry-wide approach to colour coding of
inhaled therapies for the beneﬁt of patients and carers and HCPs.
Conﬂicts of interest: The authors are all members of the UK Inhaler Group.
Funding: None.
Corresponding author: Monica Fletcher
Email address: m.ﬂetcher@educationforhealth.org
11. Improving the management of patients’ assigned COPD
treatment (IMPACT): how to affect change in primary care
Freeman D, Gerrard V, Turton J
North Norfolk Clinical Commissioning Group (CCG), UK
Brief outline of context: The Project aimed to use a COPD risk algorithm
designed by REG (Respiratory Effectiveness Group) and the author to assess its
use in Primary Care. The data extraction used for the risk assessment was
performed by OPC (Optimum Patient Care) and this process produced a
detailed spreadsheet from which practices were able to identify patients who
needed alternative treatments for their respiratory disease, including those
patients with COPD who should have had their high dose inhaled
corticosteroid (ICS) reviewed.
Outline of problem: Like many Clinical Commissioning Groups in England,
North Norfolk Clinical Commissioning Group (CCG) has had to look at ways of
reducing emergency admissions. Between 2013 and 2014 there was a 30%
increase in COPD admissions and a three fold variation between practices
within the CCG, and so the CCG decided to focus on ways to address this.
Separately the prescribing advisers had identiﬁed that many practices had
large numbers of patients with COPD, on high doses of ICS (as part of ICS/
long acting beta2 agonist combinations) who did not ﬁt the guideline criteria
for such therapies. Reducing these costs alongside reducing COPD exacerba-
tions and admissions was the main aim of IMPACT.
Assessment: IMPACT was delivered in many ways, 15 out of 19 practices agreed
to take part and the data extraction was performed by OPC in the middle part
of 2015. The risk algorithm identiﬁes patients at risk of 2 or more exacerbations
in the next 12 months and practices were encouraged to identify this group of
patients using the spreadsheet and also to identify a list of patients whose ICS
should be reviewed. Mentored clinics were performed using DF, VG and other
respiratory specialist nurses from Norfolk. The aims of the mentored clinics
were to encourage nurses to use self management plans, refer to Pulmonary
Rehabilitation and use strategies proven to help patients at risk, and to
encourage them to use a simple algorithm to review those patients on high
doses of ICS and step down or stop if the review process allowed.
Strategy: Performing the mentored clinics identiﬁed wide variation in the
standard of respiratory nurses providing care across the CCG, from excellent to
nurses who by their own admission, were neither expert or given sufﬁcient
time to do any more than a brief QOF review. Feedback was taken from the
practice nurses about the mentored clinics and any further educational needs
they may have. As a result a structured process of education has begun, and
the CCG has identiﬁed that a formal respiratory team including the authors, a
respiratory consultant, the PR lead and the local community matron should be
formed and a respiratory pathway designed and implemented.
Measurement of improvement: Data extraction is underway for the exacerba-
tion and ICS prescribing data. Already there has been a difference show in
admission data between the practices which took part and those which did
not. This part of the project focussed on the nurse education element. The vast
majority of the feedback was positive, although some nurses felt the
preparation could have been better in terms of help using the OPC
spreadsheet.
Lessons learnt: In future if we were to repeat the mentored clinics, we would
have a pre- clinic telephone call to review how the nurses had used the
spreadsheet to select patients. Many nurses assumed that the search would be
Abstracts
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complete and that no further work would be needed from them. There were
also issues with some searches performed at some practices which had to be
repeated. The main lesson has been that how starting with a project which ﬁts
the needs of the CCG can result in the ﬁtting the desires of the authors - i.e. to
have a fully integrated respiratory network ﬁtting in with the "working at scale"
ethos of forming an MCP.
Message for others: Use a computer based interrogation system as a start for a
project, it saves time & standardises data across the CCG. Use the 5 year FV as a
way into this, and galvanise practices into aspiring to provide the same level of
care as the very best practice in the patch. This may mean that they have to
provide care in a different way, so ensure that the route to that care pathway is
well signposted for them, easy to follow, and allow them to go slowly - one
step at a time.
Conﬂict of interest: DF has received payment from AstraZeneca, Boehringer
Ingelheim, Novartis & Pﬁzer in the last 12 months for providing educational
meetings or attending conferences. DF is paid by North Norfolk Clinical
Commissioning Group for some of the education sessions and pathway
development work.
Funding: The project was funded by a Quality, Innovation, Productivity, and
Prevention (QIPP) project originated from North Norfolk Clinical
Commissioning Group.
Corresponding author: Daryl Freeman
Email address: daryl.freeman@icloud.com
12. Towards person-centred care: development of a patient
support needs tool for patients with advanced chronic
obstructive pulmonary disease (COPD) in primary care
Gardener AC, Ewing G, Farquhar M
University of Cambridge, UK
Aim: Patients with advanced COPD have difﬁculty reporting their support
needs to health care professionals, undermining person-centred care and
support. A new approach, the Support Needs Approach for Patients (SNAP),
informed by, and modelled on, the evidence-based Carer Support Needs
Assessment Tool (CSNAT), may enable patients to express their support needs
and start person-centred conversations. SNAP is underpinned by an evidence-
based tool to help patients consider and express their support needs. This
study aims to develop the SNAP tool, suitable for use in clinical practice.
Method: Two-stage qualitative study. (1) Domains of need in advanced COPD
were identiﬁed through a rapid review of the literature, analysis of data from
the Living with Breathlessness Study (n= 20 purposively sampled patients with
advanced COPD) and patient focus groups. (2) A draft SNAP tool was
developed based on the identiﬁed domains of need, then reviewed and
reﬁned in stakeholder workshops to ensure acceptability and suitability for
clinical practice.
Results: The study is on-going but preliminary ﬁndings indicate that the tool
will consist of a brief set of questions which ask patients to consider whether
they need more support in relation to a range of broad areas (domains) of
need such as practical help in the home, knowing what to expect in the future,
understanding their condition and managing symptoms.
Conclusion: The tool has the potential to help patients with advanced COPD
identify and express their support needs to enable delivery of person-centred
care. Future work will test tool validity and feasibility.
Conﬂicts of interest: None.
Funding: This report is independent research funded by the National Institute
for Health Research School for Primary Care.
Corresponding author: Carole Gardener
Email address: acg68@medschl.cam.ac.uk
13. “What are the experiences of parents bringing their pre-
school child with a cough to the GP, and what can clinicians
learn about consultations with parents from parental
descriptions of these experiences?”
Glaze J
University of West London, UK
Outline: The National Health Services (NHS) is under pressure to provide
services, GPs are picking up work in commissioning services and trying to
outwork them. The study offers a service user perspective in an attempt to
understand if there is a better way to give parents the means of reassurance
rather than resorting to the GP in all cases. The study outcomes highlight
some misconceptions around parental expectation.
Outline of problem: One of the most common presentations in GP surgery is
cough in the pre school age group. Parents worry about cough and have little
knowledge about it's purpose as part of the bodies protective mechanism.
Overworked GPs may ﬁnd themselves unable to consult effectively due to
time pressures. Children may be being taken to A/E unnecessarily.
Parents fear cough in this age group due to it's association with more serious
disease. They see the GP as the expert and want their child to be seen by an
expert. GPs are overworked and are attempting to move some disease
management to nurses. There is still an international problem of overuse of
antibiotics for self limiting disease What happens in the consultation room
makes a difference to patient understanding and ability to cope.
Strategy: An understanding of parental perceptions is needed to plan a
strategy of culture change around when it is appropriate to see a
particular health care professional. GPs and nurses need to be able to
consult well in all cases so that outcomes are appropriate for parent, child
and the service Parents need to be convinced that they are able
to keep children safe using a step wise approach to symptoms of
disease. Tools to enable this approach need to be consistent and widely
available.
Measurement of improvement: The study was a fact ﬁnding mission and will
not demonstrate improvement at this time. Results did suggest that the
more thorough the parent felt the consultation was, even without
"treatment", the less likely they were to seek help elsewhere (A/E or 111).
Inappropriate use of services will reduce overall cost of provision. Reduction
in antibiotic use will reduce resistance. Parents value thoroughness at
consultation above all else, they have a strong trust in GPs who exhibit
this trait.
Message for others: We need to look at how the service is provided before we
can change how we provide the service.
Conﬂict of interest: None.
Funding: Self funded
Corresponding author: Janet Ella Glaze
Email address: jan.glaze@nhs.net
14. ‘I’m hoping for some advice…’. Barriers and facilitators to
adherence to inhaler therapy in adolescents with asthma:
insights from an online forum
De Simoni A, Grifﬁths CJ
Centre for Primary Care and Public Health, Barts and The London School of
Medicine and Dentistry, Queen Mary University of London (QMUL), UK
Aim: To explore the barriers and facilitators to inhaled asthma treatment in
adolescents with asthma.
Method: Qualitative analysis to posts about inhaler treatment in adolescents,
from an online forum for people with asthma, between 2006 and 2016.
Analysis informed by a Perceptions and Practicalities Approach,
Fifty-ﬁve forum participants (39 adolescents, 5 parents, 10 adults with asthma),
identiﬁed using search terms ‘teenager inhaler’ and ‘adolescent inhaler’.
Abstracts
5
Published in partnership with Primary Care Respiratory Society UK npj Primary Care Respiratory Medicine (2016) 16077
Results: Adolescents, parents and adults with asthma contributed to online
discussions. Forgetfulness, poor inhaler technique and routines, difﬁculties
managing practicalities of medications, and families not understanding
asthma were practical barriers. Prompting and monitoring inhaler treatment
were described as helpful, with adolescents beneﬁting from self-monitoring
through diary or digital apps.
Denial of asthma, age-related immaturity and not-taking-inhalers as attention
seeking were recognised perceptual barriers. Adolescents and adults with
asthma (but not parents) additionally described concerns related to attributed
side effects (e.g. weight gain, spots, tremor) and social stigma, i.e. asthma
being seen as weakness and confused with anxiety or attention-seeking,
resulting in ‘embarrassment of taking inhalers in public’, especially in mild-
moderate or no-wheezes-asthma. Building a good rapport with own doctor,
actively seeking inhaler adjustments and learning to deal with side effects
were facilitators to optimal adherence. Parents were instrumental in
promoting sense of responsibility for asthma treatment. Adolescents and
adults with asthma reported advice/techniques to deal with people reactions
and acceptance of asthma.
Conclusion: This online forum reveals a rich insight into the practical and
perceptual barriers to adherence to asthma inhaler treatment experienced by
adolescents. Interventions that prompt and monitor inhaler use hold potential.
Exploring parents’ beliefs about asthma diagnosis and their role in dealing
with practical barriers of treatment in clinical consultations might be beneﬁcial.
The social stigma of asthma and its role in adherence to inhaler taking might
be underestimated and warrant further research. There is need to improve
public awareness of mild/moderate and no-wheeze asthma.
Conﬂicts of interest: none.
Funding: Anna De Simoni is funded by a National Institute for Health Research
Academic Clinical Lectureship.
Corresponding author: Christopher Grifﬁths
Email address: c.j.grifﬁths@qmul.ac.uk
15. The introduction of a hospital at home (HAH) service for
acute exacerbation of COPD (AECOPD) patients
Hammond MJ, O’Connor J, McBride C
Liverpool Community Health NHS Trust, UK
Brief outline of context: The addition of a HAH service to an existing early
supported discharge (ESD) service was introduced to positively impact on
hospital admission numbers and move care from hospital to home.
Outline of problem: COPD is a common cause of emergency admission, with
emergency hospital admissions increasing nationally by 13% from 2008-2015
(Stone et al. 2015). This represents a signiﬁcant cost to the National Health
Services (NHS) of between £810m to £930m yearly (www.dh.gov.uk).
Assessment: ESD has successfully reduced number of in-patient bed days.
Scope for admission avoidance by the addition of HAH was identiﬁed.
Strategy: Patient is seen within 2 hours of GP HAH referral and provided
support until no longer hospital admission risk. COPD management optimised
prior to discharge from service.
Measurement of improvement: Ninety-one percent of HAH patients successfully
managed at home, 24.5% reduction in admissions, 88% of patients rated
service as excellent, 12% as very good.
Effects of changes: Seven percent increase in referrals to ESD and HAH
combined. HAH as a percentage of total referrals has increased from 31%
2013-14 to 52.5% 2015-16. The introduction of HAH service has increased
service demand. However, there has been a signiﬁcant shift in activity from
secondary care to the home setting and a positive impact on hospital
admissions. HAH is a safe alternative to hospital admission for a signiﬁcant
cohort of AECOPD patients.
Conﬂicts of interest: None.
Corresponding author: Michael Hammond
Email address: michael.hammond@liverpoolch.nhs.uk
16. The power of spirometry as a "teachable moment" to
"INSPIRE" smoking cessation
Houghton I, Heyes L
Respiratory Training Services, UK
Outline: In the course of a 5-year project Public Health Blackpool took the offer
of a Lung Health Check (spirometry and lung health information) out into
community and workplace settings across the Blackpool Clinical Commission-
ing Group (CCG) area.
Outline of problem: Blackpool has one of the lowest life expectancy for men in
England. Smoking related diseases account for at least half of the health
inequalities.
Aim: As the intervention evolved a series of scripts were devised tailored to the
individual, having a common theme of plain non-clinical language, lung
health, lung disease and lung age. The aim being to increase the motivational
tension and trigger a quit attempt in the smokers.
Strategy: Three-hundred and twenty-seven events were held over the 5 years,
testing 4660 individuals, 2051 of whom were smokers.
Measurement of improvement: In a sample audit 49% of the smokers tested
subsequently registered a quit attempt with the local National Health Services
(NHS) Stop Smoking Service. The ”INSPIRE” intervention does have the
potentional to act as a ”teachable moment” triggering behavioral change and
adopting more positive health enchancing behaviours,which if adopted more
widely particulary in a primary care setting could help towards increasing the
number of quit attempts and reducing the burden of lung disease.
Lessons learnt: When explaining spirometry readings it is vital to use plain
non-clinical language and in order to trigger a quit attempt use positive
messages stressing short term quick gains for the individual.
Message for others: Plans are now in place to deliver training on the "INSPIRE"
model to all primary care and community teams across the Blackpool CCG
area and we hope to report the outcomes in the future.
Conﬂict of interest: None.
Funding: None.
Corresponding author: Irene Houghton
Email address: irene.houghton@btinternet.com
17. The features patients ‘want’ in a smartphone app to support
asthma self-management: a review of the online discussion
forums
Hui CY, Walton R, McKinstry B, Wolters M, Vasileiou E, Pinnock H
Usher Institute of Population Health Sciences and Informatics, Asthma UK Centre
for Applied Research, The University of Edinburgh, UK
Aim: Self-management with an action plan, as opposed to passive self-
monitoring, improves health outcomes. Mobile technology, incorporating
education, personalised asthma action plans and facilitating professional
support, is an option for supporting asthma self-management. Clinical
research has focussed on health-related outcomes rather than informing the
features that patients want and will use in a self-management app. We
therefore reviewed conversations in online discussion forums to answer the
questions: Which mobile technology features are widely discussed by people
with asthma? How do people feel about those features? What are the features
they ‘want’ in an app?
Method: We systematically searched Google for ‘asthma’ ‘forums’. Eligible posts
were assessed by two reviewers and we identiﬁed the frequency with which
features were mentioned and synthesised the perceptions thematically.
Results: From 25 forums, we included 22 posts (November, 2013 –November
2015). 42 people with asthma commented on 44 application features which
we grouped into ﬁve categories (self-monitoring, feedbacks/advice, profes-
sional/carer support, reminders, and others e.g. stress management). Feelings
ranged from ‘positive’, ‘appreciative but worried (e.g. about conﬁdentiality)’,
‘nothing unique’, ‘doubtful’ and ‘negative’. The majority of comments about
apps incorporating monitoring peak ﬂows, symptoms and medication usage
were positive, but without explicit mention of action plans. Smart gadgets,
such as electronic inhaler logs provoked a range of responses from positive to
negative.
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Conclusion: Smartphone apps for people with asthma have generated a range
of comments on social forums, with the most interest in logging health status
with symptoms or peak ﬂows (sometimes with novel gadgets). The lack of
discussion about action plans, suggests that today’s apps are limited to self-
monitoring rather than self-management. Further research is needed to
understand this limitation and the features associated with adoption and
adherence to self-management.
Conﬂicts of interest: None.
Funding: CYH is funded by a PhD studentship from the Chief Scientist Ofﬁce.
Corresponding author: Chi Yan Hui
Email address: io.hui@ed.ac.uk
18. The impact of incentives on the implementation of asthma
or diabetes self-management: a systematic review
Jackson T, Heaney L, Shields M, Kendall M, Hui CY, Pearce C, Pinnock H
Asthma UK Centre for Applied Research, Usher Institute of Population Health
Sciences and Informatics, The University of Edinburgh, United Kingdom
Aim: To systematically review the evidence investigating the impact of
ﬁnancial incentives for implementation of supported self-management on
organisational process outcomes, individual behavioural outcomes, and health
outcomes for individuals with asthma or diabetes.
Method: We followed Cochrane methodology, using a PICOS search strategy
to search 8 databases, including a broad range of implementation
methodologies. Studies were classiﬁed by robustness of methodology,
number of participants and quality score (Cochrane). We used narrative
synthesis due to heterogeneity.
Results: We identiﬁed 2017 articles; 11 met our inclusion criteria. Self-
management outcomes identiﬁed were practice or practitioner performance
scores for HbA1c testing (n= 9), asthma self-management plan (n= 1) and
emergency department (ED) visits (n= 1). Three studies were part of a larger
incentive scheme; one focused on asthma; seven focused on diabetes. In one
asthma study, the proportion receiving 'perfect care' (which includes written
self-management plan) increased, and there were fewer ED visits in another
study. In 9 diabetes studies, GP performance scores improved in 2/9, were
unchanged in 6/9 and deteriorated in 1/9.
Results for the impact of FI on the implementation of self-management were
mixed. Overall, the evidence suggests no impact in diabetes and a single study
showed improved processes in asthma. Further research is needed to conﬁrm
these ﬁndings and understand how FI impact on care.
Conﬂicts of interest: None.
Funding: The University of Edinburgh College of Medicine and Vetrinary
Medicine (CMVM) PhD Studentship [Asthma UK Centre for Applied Research
PHD/14/16].
Corresponding author: Tracy Jackson
Email address: tracy.jackson@ed.ac.uk
19. Implementing structured Medicine Use Reviews (MURs) for
people with Asthma
Jongepier L, Murphy A, Leong N, Ord C, Donyai P
East of England Respiratory Clinical Network (CN), UK
Outline: We examined the use and practical implementation of the SIMPLE
Asthma IT Platform (SAP) with community pharmacists.
Outline of problem: Forty-three percent of people who died of asthma did not
have regular primary care asthma reviews in the last year before death.
Twenty-two percent of patients miss their GP appointment (NRAD, 2014).
Enhancing the role of the community pharmacists is key to achieving good
asthma outcomes.
Assessment: Little guidance is given on what constitutes a good quality MUR,
resulting in variation of the quality of MURs. The SAP provides a structured
template of asthma care for pharmacists, designed to ensure high-quality
MURs are delivered consistently.
Strategy: We facilitated the implementation of the SAP in 6 community
pharmacies, preceded by asthma training. We collaborated with the University
of Reading to examine the effects on the quality of the asthma MURs by
independently measuring patient satisfaction.
Measurement of improvement: Structured pharmacists’ feedback and analysis of
non-identiﬁable patient service data. Ten patients received a comprehensive
asthma review. Patients were advised on self-management, inhaler technique
and smoking. 4 patients did not have an asthma review during the past
12 months. Only 2 patients had well controlled asthma deﬁned by the RCP 3
Questions.
Lessons learnt: Pharmacists valued the training and the SAP highly, however its
implementation was challenging and its use was poor. The main reasons given
were time constraints and IT issues. The SAP is a promising tool to support
MUR delivery. A larger and longer study is required to fully evaluate its
practicability and impact.
Conﬂicts of interest: None.
Funding: The Clinical Network provided £3,500.00 funding.
Corresponding author: Lianne Jongepier
Email address: lianne.jongepier@nhs.net
20. Owning my asthma; An enhanced self-management
initiative for 14-19 year olds
Lynch S, Kearney S, Hueppe M, Day T, Dominey R, Dewey A
IW NHS Trust, IW CCG, Wessex AHSN, Message Dynamics and University of
Portsmouth
Brief outline of context: Over 1.1 million children in the UK are currently being
treated for asthma. The equivalent of a classroom full of children dies every
year from asthma.
Outline of problem: People without asthma action plans are four times more
likely to need to go to hospital for their asthma. Only a third of children asked
said they had a written asthma action plan and just a quarter were getting all
three elements of routine management for their asthma.
Assessment: A year on year increase in A&E attendances for asthma in 14-19
year cohort shows that there is a need for a clinically appropriate programme/
to promote effective and enhanced asthma self-management; a key
recommendation from the National Review of Asthma Deaths.
Strategy: An asthma review with a Respiratory Nurse where they were issued
with a digital Peak ﬂow meter, an Asthma Action Plan and signed up to
receive weekly automated calls. They were reviewed after two months and
offered an incentive if they completed the project.
Measurement of improvement: Evidence of improved concordance through
review of prescribing data, exacerbations, hospitalisation rates and self-
reported wellbeing. A total of 83% felt better able to control their asthma,75%
said that they understood their asthma better. More than 50% felt that their
asthma symptoms had improved, 60% ACT score had improved.
Lessons learnt: Teenagers require more input and it is important to build
relationships with them. This group engages readily with technology.
Engaging colleagues from other practices proved challenging.
Conﬂict of interest: None.
Funding: Wessex Academic Health Science Network Funding, support from Isle
of Wight Clinical Commissioning Group and IW National Health Services Trust.
Message Dynamics provided licences at a reduced fee.
Corresponding author: Sonya Lynch
Email address: sonyalynch123@aol.com
21. The use of electronic alerts in primary care computer
systems to identify the over-prescription of short acting
beta2-agonists in people with asthma: a systematic review
McKibben S, De Simoni A, Bush A, Thomas M, Grifﬁths C
Asthma UK Centre for Applied Research, Queen Mary University London, UK
Aim: Frequent use of short-acting beta2-agonist (SABA) inhaler medication is
an indicator of poor asthma control and a risk factor for asthma exacerbations.
Furthermore, the National Review of Asthma Deaths (NRAD, 2014) identiﬁed
the excessive prescribing of SABA as a modiﬁable risk factor for asthma deaths.
Clinical guidelines recommend those using more than one SABA per month
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should have an early clinical review with recommendations supporting the
electronic surveillance of SABA prescribing in primary care. This review aims to
evaluate the effectiveness of electronic prescribing alerts within computerised
clinical decision support systems (CDSSs) in primary care to identify the over-
prescription of SABA in patients with asthma.
Method: We included randomised controlled trials that used electronic alerts
within CDSSs to identify SABA over-prescribing in primary care. We
systematically searched ﬁve electronic databases from January 1990 to July
2016. The primary outcome was SABA over-prescription/100 patients.
Secondary outcomes were changes in prescribing (health care process
measures) and asthma exacerbations and health service use (clinical
outcomes). Study quality was assessed using the Cochrane Risk of Bias Tool.
Results: We have identiﬁed 2930 titles from January 1990 – July 2016 with less
than 5 studies eligible for inclusion. The systematic review is ongoing and we
will present our analysis of included papers.
Conclusion: A small number of trials exist that examine the use of alerts in
CDSSs to identify excessive SABA prescribing. We will use our ﬁndings to
inform the development of electronic alerts to identify patients over-
prescribed SABA in primary care.
Conﬂicts of interest: None.
Funding: Queen Mary University of London/Asthma UK Centre for Applied
Research.
Corresponding author: Shauna McKibben
Email address: s.m.mckibben@qmul.ac.uk
22. Evaluation of the PREPARE self-management education
programme for patients with mild to moderate COPD
Mitchell EM, King SK
Gloucestershire Care Services, Gloucester, UK
Aim: To establish if an education-only intervention for patients with mild to
moderate COPD is effective in changing knowledge and conﬁdence in disease
management.
Method: Patients with COPD and a Medical Research Council (MRC)
breathlessness score of less than 3 referred by GP practices in the Forest of
Dean and Stroud districts of Gloucestershire between April 2015 and March
2016 were offered the PREPARE programme: three two-hour sessions of group
education. Eligible patients who were unable to attend a Pulmonary
Rehabilitation course were also offered places. Classes were offered on
weekdays, evenings and weekends and included: understanding your lung
condition, beneﬁts of exercise, medication and inhaler technique, managing a
ﬂare-up, managing breathlessness and continuing to exercise. All patients
were issued with an exercise DVD and COPD resource materials. Outcome
measures were the Bristol Knowledge and Skills Questionnaire (BCKQ) and the
Mastery component of the Chronic Disease Questionnaire completed at the
start and ﬁnish of the course.
Results: Of 136 referrals, 85 people (62%) attended the programme with a
completion rate of 92%. Overall 92% of patients increased their BCKQ scores,
6% decreased and 2% were unchanged. Of 49 Mastery scores, 55% increased,
24% decreased and 20% remained unchanged. Sixteen patients requested
referral to local Respiratory Exercise groups. Ongoing six month follow-up is
suggestive that gains have been maintained.
Conclusion: An education-only intervention for patients with mild to moderate
disease is effective in improving the knowledge and conﬁdence of patients
with COPD and may be a cost – effective method of offering improved self-
management at an early stage of disease.
Conﬂicts of interest: None.
Funding: Half by Boehringer Ingelheim, who also donated the educational
materials, and half by the National Health Services Gloucestershire Clinical
Commissioning Group.
Corresponding author: Esther Mitchell
Email address: esther.mitchell@glos.nhs.uk
23. Effect of structured intervention on unscheduled asthma
care in North London
Nicholson E, Hodson M, Rajakulasingam R
City & Hackney GP Confederation/Homerton University Hospital, London, UK
Outline of problem: Asthma has been reported as one of the main causes of
frequent Emergency Department (ED) attendances. The National Review of
Asthma Deaths (NRAD), Royal College of Physicians report 'why asthma still
kills' published in 2014 highlights that frequent attenders to ED have an
increased risk of requiring further medical intervention.
Assessment: A gradual rise in unscheduled ED attendances among 4 16 year
old population with asthma had been recorded over the previous 2-3 years.
The pilot sought to understand why these attendances occurred and whether
targeted intervention by a respiratory clinical nurse specialist would improve
outcomes.
Strategy: A pilot scheme was initiated in City & Hackney in January 2015
funded by City & Hackney Clinical Commissioning Group (CCG) for 14 months
to audit ED asthma attendances and admissions among the 416 years old
population and offered a targeted intervention programme to improve
outcomes and reduce ED attendances. An integrated approach was proposed
with a respiratory clinical nurse specialist liaising across primary and secondary
care offering integrated and patient-centered care to impact ED frequent and
infrequent asthma attendances.
Measurement of improvement: This work elaborates on the work of the
previous poster submission entitled 'What impacts on ED Attendances'
presented at the PCRS annual conference in 2015 and evaluates the outcome
of a robust programme of structured care for adult asthma patients and the
impact of the integrated primary and secondary care intervention by the
respiratory clinical nurse specialist on asthma attendances and admission,
particularly among the frequent ED attenders.
Effects of changes: Attendances of frequent and infrequent asthma attenders
were audited over the span of the pilot scheme Measuring patient outcomes,
medication adherence and asthma control.
Lessons learnt: Educational intervention and case management of frequent
asthma attenders can positively impact hospital attendances and admissions.
Easy integrated access to secondary care clinicians beneﬁts patients and
primary care clinicians. Targeted educational sessions within primary and
secondary care increases clinician conﬁdence and expertise. The large
percentage of ﬁrst time attenders at ED in 12 months with asthma symptoms
highlights the need for better access and education of asthma within
primary care.
Clinical Commissioning Groups and secondary care providers need to consider
sustainable longer term funding of pilots and programmes to ensure the
improved longer term outcomes and care continue among this cohort of
patients. Asthma and respiratory symptoms in the paediatric population
continues to generate uncertainty amongst primary care clinicians, an
integrated strategy incorporating and transitioning paediatrics into adult
respiratory care requires greater priority.
Conﬂicts of interest: None.
Funding: None.
Corresponding author: Ellen Nicholson
Email address: enicholson2@nhs.net
24. Development of Foundation Level e-Asthma E-learning
Resource
Pearce LJ1, Marsh V2, Raybould L1, Jongepier L1, Blackmore A3
1East of England (EoE) Respiratory and Paediatric Asthma Clinical Network, UK;
2Education for Health; 3Health Education England
Outline: E-Asthma resource speciﬁcally targeting non-asthma specialist
healthcare professionals who come into contact with children/adults with
asthma. Development commissioned and led by EoE Respiratory and
Paediatric asthma CNs, a key deliverable for National Paediatric Asthma
Collaborative. Three way partnerships between East of England Respiratory
Clinical Network, Health Education England e-learning healthcare programme
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who designed, developed and host the e-Learning sessions and Education for
Health who wrote the content.
Outline of problem: National Review of Asthma Deaths and EoE audit identiﬁed
lack of asthma knowledge and conﬁdence. Development of online
educational resource may address key unmet need in current system.National
reports and EoE strategy meetings identify gaps in access to learning.
Supported by range of documents.1-3
Aligns with Five Year Forward View - Project team developed e-Asthma.
Clinical reviewers ensured content accuracy. Three Clinical Commissioning
Groups (CCG) approved as early adopters and evaluators.
Measurement of improvement: QA process throughout content development
phase. E-Asthma being tested across whole CCGs with questionnaires
completed pre, post and 3 months post.
Effects of changes: Yet to be formally evaluated, anticipated beneﬁts of rolling
out training across whole system include increased healthcare professionals
conﬁdence, consistency of care, appropriate prescribing, reduced admissions,
better compliance, increased use of asthma action plans, improved patient/
family experience.
Lessons learnt: Feedback will be analysed. Anonymised data will be published
alongside national release of e-Asthma. E-Asthma free of charge. System is fully
auditable for monitoring uptake across local systems.
Conﬂicts of interest: None.
Funding: East of England Respiratory Clinical Network on behalf of National
Health Services England with ongoing support from Health Education England
(HEE). Project funding £37,000.
Corresponding author: Linda Pearce
Email address: linda.pearce@wsh.nhs.uk
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25. Aneurin Bevan University Health Board Community
Pharmacy Respiratory Medicines Adherence Project
Curson MC, Reynolds J, Evans RJ, Bright S
Aneurin Bevan University Health Board, UK
Aim: The project explored the practicality and beneﬁt of providing an asthma
review service in a community pharmacy setting. By providing patients who
fail to attend annual reviews at the GP practice with a review at the place
where they collect their medication, the project aimed to improve patient
outcomes, support prudent prescribing and quantify the beneﬁt of pharmacist
intervention.
Method: Pharmacists and GPs worked collaboratively to identify suitable
patients who were then reviewed in the pharmacy utilising a consultation
framework . Smoking status, asthma control, ACT score, inhaler technique and
understanding were assessed and recorded. Records were shared with the GP
and the pharmacists followed up the patient 6-8 weeks later. Patients,
pharmacists and GPs were asked for feedback on the service.
Results: A total of 5 pharmacies took part in the project and 2 were able to
collaborate with a GP practice to perform 45 initial reviews. Pharmacists made
an average of 2.6 interventions per review. Poor inhaler technique, poor
expectations as to what good asthma control was and misunderstood
treatment regimes were common themes. Over use of SABA and underuse of
inhaled corticosteroid (ICS), was identiﬁed in 24% and 22% of patients
respectively. A total of 29 patients were followed up and 22% had a clinically
signiﬁcant increase in ACT score. Feedback from patients, GPs and pharmacists
was positive.
Conclusion: The project proved the concept of a community pharmacy service
to improve the use of respiratory medicines in patients who don’t attend GP
asthma reviews.
Conﬂicts of interest: None.
Funding: Existing community pharmacy funding allocation. Aneurin Bevan
University Health Board.
Corresponding author: Jacqueline Reynolds
Email address: jackie.reynolds@wales.nhs.uk
26. Do children really outgrow asthma?
Goodwin D
GP, Shrewsbury, UK
Outline: Parents used to be told not to worry about being informed their child
had asthma as they “would most likely grow out of it”. Literature searches
show there are some characteristics that are correlated with the veracity of this
advice, but it does seem at odds with the phenotypic expression of a genetic
tendency – which would make the diagnosis lifelong and dependent upon
the trigger to be expressed again.
Having conducted longitudinal audits of asthma exacerbations over several
years I observed that children were susceptible to these mainly through lack of
compliance. Looking at the status of all our asthma patients it was apparent
that we were good at “stepping up” the asthma treatment, but not “stepping
down”.
Outline of problem: Any asthma medication use after the age of 13 years will
cause difﬁculty if not disqualify any application to join the British armed
services.
Age at diagnosis and practical difﬁculties lead to a variety of methods being
used to make an asthma diagnosis. Once made, there is seldom use of
reversibility tested spirometry when the child has competence.
Strategy: I suggest that the diagnosis made on pragmatic, but less exact
methods may not be asthma. By obliging those with asthma to have a reliever
inhaler available at all times, we are penalizing the compliant in future career
choices.
Measurement of improvement: The youngest age at which asthma was
“diagnosed” was 10 months to 18 years.
Effects of changes: The main method of diagnosis was peak ﬂow diary with
improvement on use of beta agonists. The least used was reversibility
spirometry.
Lessons learnt: Record asthma control step at each review and step down as
readily as stepping up. Invite all 11 year olds to have reversibility spirometry for
security of diagnosis.
Conﬂict of interest: None.
Funding: None.
Corresponding author: Daryl Goodwin
Email address: darylgoodwin@doctors.org.uk
27. An electronic resource to map respiratory inhaler
prescribing options against the major respiratory pathways
Saleem A, Rehman B
NHS London Procurement Partnership (LPP), UK
Brief outline of context: Sanchis et al. (Chest 2016) demonstrated again that
patients are still not using inhalers properly in the UK, there are 100+ unique
drug and device dose combinations with 18 different device types.
Outline of problem: Primary care healthcare professionals (HCPs) struggle with
the permutations available and where to direct patients to reinforce inhaler
technique. Many patients therefore end up inadvertently moving up or down
pathways inappropriately demonstrated in COPD by White et al. (PLoS ONE
2013).
Resources are limited in provision of device information and focus on drug
constituents. Resources for inhaler technique video demonstrations are
scattered across different domains. Primary care HCPs are often uncertain
where to direct patients to reinforce inhaler technique.
Strategy: Electronically mapping every inhaler option against their correct
place in the national respiratory guidelines whilst providing inhaler technique
videos at source (for both clinicians and patients).
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Measurement of improvement: A website and app with reproductions of the
national respiratory pathways with inhalers mapped against each step and
inhaler technique video links at each prescribing option.
Effects of changes: Changes to prescribing patterns, analytics of; clinician,
patient and geographical use.
Lessons learnt: Still learning and producing the content, so much learning to
show/share.
Respiratory prescribing is complex and ever changing with device and drug
issues, we need dynamic resources to cater for these complexities.
Conﬂict of interest: Azhar Saleem - honoraria speaking fees from AstraZeneca,
Pﬁzer and TEVA, Ben Rehman - as above only for TEVA.
Funding: Dr Azhar Saleem - National Health Services London Procurement
Partnership, Mr Ben Rehman - UKMI. Cost of the website and app- unrestricted
MEG from AstraZeneca, Boehringer Ingelheim, Chiesi, National Association for
Patient Participation (NAPP), Pﬁzer and TEVA.
Corresponding author: Azhar Saleem
Email address: azhar.saleem@nhs.net
28. Lay health workers in pulmonary rehabilitation-recruitment
and training of COPD patient volunteers
Gilworth G, Tuffnell R, Hogg L, Taylor SLC, Lewin S, Hopkinson NS,
Wright AJ, White P
King's College London, UK
Aim: Pulmonary Rehabilitation (PR) is the most effective treatment for the
symptoms of COPD but less than half of referred patients complete it (1) Lay
health workers (LHWs) have improved uptake of healthcare interventions in
other settings (2) but have not previously been used in PR. To test the
feasibility of using COPD patients, trained as LHWs, to enable other COPD
patients to beneﬁt from PR.
Method: Patients successfully completing PR were invited to volunteer as
LHWs. Training included conﬁdentiality, role boundaries and the learning and
application of behaviour change techniques to address known barriers to PR
attendance. Patients newly referred for PR were invited to accept LHW support
by letter, phone and face to face interaction.
Results: Twenty three (21%) of 110 patients approached applied to become
LHWs. Fifteen (14%) completed 3 training days and joined a mentored group
prior to supporting newly referred patients. Reasons for non-completion of
training included health and social issues and concerns about impact on
beneﬁts of payments for research participation.
Letters and information leaﬂets were ineffective in recruiting newly referred
patients for LHW support (o1% response). Telephone and face to face
recruitment (at initial assessment) by the PR teams were effective (20 – 25%
response in different National Health Services Trusts). This became the main
recruitment mode.
Conclusion: COPD patients can be recruited and trained as LHWs to encourage
participation in PR. Personal contacts were the most effective method of
recruiting patient participants for LHW support. The effectiveness of LHWs will
be tested in a deﬁnitive clinical trial following this feasibility study.
Conﬂicts of interest: None.
Funding: National Institute for Health Research Research for Patient Beneﬁt
(RfPB) Programme.
Corresponding author: Patrick White
Email address: patrick.white@kcl.ac.uk
29. Community Pharmacist interventions and improved COPD
management
Attar-Zadeh D, Guirguis A, Heading CE, Shah S, Shah U, Bancroft S
London North West Local Practice Forum of the Royal Pharmaceutical Society, UK
Outline: Community pharmacists are well placed to help the management of
patients with long-term conditions such as COPD.
Outline of problem: Many factors can prevent optimal care for COPD patients;
some can be addressed within a pharmacy setting by improving patient
understanding of how their condition can be managed.
Assessment: A project was undertaken by community pharmacies to support
patients in managing their condition. Data collected also provided an
overview of care patterns in the localities involved.
Strategy: The project involved 18 pharmacies, in and around NW London. Over
a 4-week period, pharmacists undertook consultations in the pharmacy with
consenting patients who were receiving medicines prescribed for COPD.
Measurements: Patients were asked questions from a semi-structured
questionnaire. Information was collected and action taken to provide inhaler
training, guidance and referral, where appropriate.
Changes: Of 135 patients, 75 were provided with inhaler training, 88 patients
were offered Medicines Use Reviews, 23 patients received guidance regarding
rescue packs, 38 patients were referred to GPs and 32 of 39 smokers were
referred to stop smoking services.
A total of 93 patients were using an inhaled corticosteroid (ICS) plus long
acting beta2 agonist (LABA) Given the low rate of hospital admissions recorded
(18% in the previous 12 months), LABA + ICS use is much higher than would
be expected for the patient group if GOLD guidelines were followed.
Lessons: Participating pharmacists reported improved patient engagement in
managing their condition, improved compliance and device use, and positive
actions from GPs such as alteration of medication dose; and issue of
rescue packs.
Message for others: Community pharmacists can improve care of COPD
patients, potentially reducing hospital admissions.
Conﬂict of interest: None.
Corresponding author: Darush Attar-Zadeh
Email address: lnwlpf@gmail.com
30. How can we reduce the prevalence of smoking further in
London in our battle to treat tobacco dependency
Attar-Zadeh D
London Clinical Senate Helping Smokers Quit, London Procurement Partnership (LPP)
Brief outline of context: How can we reduce the prevalence of smoking further
in London in our battle to treat tobacco dependency? Evidence based
National Health Services (NHS) support combined with pharmacotherapy has
shown to improve a smokers chances of stopping up to four times. Varenicline
has shown to be the most effective licensed treatment to help smokers stop
alongside NHS behavioural support. It plays a vital role in our challenge to
treat tobacco dependency and help many smokers including the sick smokers
with long term conditions. One of the ways is to increase the usage of
varenicline alongside behavioural support in primary and secondary care.
Medication is normally initiated to treat nicotine withdrawal after routine
carbon monoxide monitoring.
Outline of problem: Smoking cessation by some is seen as a public health issue.
However smoking now needs to be seen as a chronic relapsing long term
condition that needs to be treated as well as prevented e.g. cessation in COPD
is the most effective treatment and extremely cost effective. A number of
barriers may come up in our battle against tobacco dependency: (1) Seen by
some as costly to treat and prevent; (2) As prevalence drops and at times of
austerity, this most cost effective intervention to the National Health Services
(NHS) may be squeezed; (3) Clinicians often raise a number of concerns
about varenicline that make them cautious about prescribing; (4) This is
compounded by varenicline prescribing historically having been the
responsibility of smoking cessation specialists. Therefore many clinicians have
not been trained, and do not have experience, in prescribing varenicline (or
nicotine replacement therapy).
Strategy: Varenicline plays a vital role in our challenge to treat tobacco
dependency and help many smokers including the sick smokers with long
term conditions. The LPP was asked to help the LCS with extracting data from
ePACT for varenicline across London Clinical Commissioning Groups (CCG)
and also secondary care over a 3 month period. Once this data was captured,
then the LCS wanted the data on a heat map with the usage per CCG and
superimposed secondary care data so the image could tell an important story
of activity across London.
Measurement of improvement: Mapping of LPP and ePACT data for London
shows very signiﬁcant variation and overall underuse of this important cost
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effective treatment. By benchmarking the CCG and Trust average it may
encourage further usage and instil further conﬁdence. The data produced
would be relatively clean. However some CCGs have PGDs in place meaning
all varenicline use wouldn’t be captured.
Effects of changes: With the LCS guide ‘Why and how to prescribe varenicline in
hospital’, these maps have informed review of hospital and CCG formularies
with the aim of raising awareness, encouraging appropriate prescribing and
increasing access to varenicline. http://www.londonsenate.nhs.uk/wp-content/
uploads/2015/04/Why-and-how-to-prescribe-varenicline-in-hospital.pdf.
Lessons learnt: Clinicians often raise a number of concerns about varenicline
that make them cautious about prescribing. This is compounded by
varenicline prescribing historically having been the responsibility of smoking
cessation specialists. Therefore many clinicians have not been trained, and do
not have experience, in prescribing varenicline (or nicotine replacement
therapy). With the LCS guide ‘Why and how to prescribe varenicline in
hospital’, these maps have informed review of hospital and CCG formularies
with the aim of raising awareness, encouraging appropriate prescribing and
increasing access to varenicline.
Message for others: Start or continue to offer cost effective life saving
interventions e.g. varenicline, buproprion, or NRT plus support to treat tobacco
dependency. It is good news that the number of people dying from smoking
continues to fall, however, smoking remains the single biggest cause of
preventable ill-health and death in the UK and the number admitted to hospital
with smoking-related diseases is still going up. If we are to reduce the burden of
smoking-related disease on the over-stretched NHS it is essential that smokers
are given the best possible support to quit.
Conﬂict of interest: Attar-Zadeh D has accepted honoria from all pharmaceutical
companies involved in evidence based stop smoking treatment alongside
behavioural support.
Funding: London Clinical Senate (LCS) with the support of the NHS London
Procurement Partnership (LPP) and London Clinical Senate (LCS) funded the
whole project.
Corresponding author: Darush Attar-Zadeh
Email address: d.attar-zadeh@nhs.net
31. Seasonal Inﬂuenza Vaccine effectiveness in Asthma:
a systematic review
Vasileiou E, Sheikh A, Butler C, Simpson C
The University of Edinburgh, UK
Aim: To assess the effectiveness and safety of the seasonal inﬂuenza
vaccination in people with asthma.
Method: Systematic search of published literature has been conducted
through electronic databases ranged from 1970 to 2016 for experimental and
observational studies. The search has been complemented by searching
reference lists, citations and communication with vaccine manufacturers for
the identiﬁcation of additional published or unpublished literature. Both
reviewers have completed the extraction of data of eligible studies.
Results: Twenty six trials and ten observational studies were eligible for
inclusion. The majority of studies were conducted in Europe and in the USA
and including children in about half of them. The inactivated inﬂuenza vaccine
was the most common intervention and the safety of the vaccine was more
often assessed than its protective effects, especially in trials. The effectiveness
of the vaccination was assessed in all, but one observational study. Low risk of
bias was assigned in half of the randomised controlled trials (RCTs) based on
Cochrane tool. Similarly, the quality of evidence was strong in about half of the
non-RCTs and observational studies according to the Effective Public Health
Practice Project (EPHPP) tool.
Conclusion: The safety of the inﬂuenza vaccination has been extensively
assessed in experimental studies. However, there is lack of strong evidence
regarding the protective effects of the vaccine against major clinical outcomes
such as primary care consultations and hospital admissions for inﬂuenza and
related complications such as asthma exacerbation.
Conﬂicts of interest: None.
Funding: The work is funded by the Chief Scientist Ofﬁce of the Scottish
Government under grant (AUKCAR/14/03). This work is carried out with the
support of the Asthma UK Centre for Applied Research (AUK-AC-2012-01).
Corresponding author: Eleftheria Vasileiou
Email address: e.vasileiou@ed.ac.uk
32. British Thoracic Society (BTS) step therapy and control status
in a large cohort of patients in the UK
Pertsovskaya I, Christine M, Brown S, McKnight E, Haughney J
National Services for Health Improvement Ltd (NSHI), UK
Aim: In 1999, Neville et al. (1) reported the British Thoracic Society (BTS) asthma
step and a proxy measure of control in a large population of people with
asthma. We sought to replicate this work.
Method: National Services for Health Improvement Ltd (NSHI) conducted a
review of patients with asthma, part of the “IMPACT” programme. Ninety-two
practices from across the UK participated in 2015-2016 and gave consent to
use the data for research purposes. Data was extracted from GP practices’
databases. Patient demographics and asthma therapy were obtained and BTS
asthma step was calculated. Asthma control was deﬁned according to the
Global Initiative for Asthma (GINA) recommendations. A proportion of these
patients were invited for clinical review.
Results: An assessment of BTS step was made in 31657 patients. Asthma
control could be determined in 28653. The number of uncontrolled patients
was over 40% across all steps and increased signiﬁcantly from Step 1 to Step 4
(P-valueo0.0001). A subpopulation of patients was reviewed clinically by NSHI
nurses. From 2362 patients invited for review, 1926 attended and an asthma
control set was available for 1699. A similar rate of control was observed in this
cohort of patients. (46% uncontrolled at Step 1, 53% at Step 2, 58% at Step 3
and 57% at Step 4).
Conclusion: In agreement with Neville’s results, a large number of patients
remain uncontrolled. Unlike Neville, current thinking includes assessment of
inhaler technique, compliance, and other factors before increasing therapy (2).
Despite guidelines, staff training and initiatives, asthma remains poorly
controlled across BTS steps.
Conﬂicts of interest: None.
Funding: Funded by Teva UK Ltd.
Corresponding author: I Pertsovskaya
Email address: inna.pertsovskaya@nshi.co.uk
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33. Patient satisfaction with structured Medicines Use Reviews
(MURs) for people with asthma
Hindi A, Jongepier L, Murphy A, Leong N, Ord C, Donyai P
University of Reading, Berkshire UK
Aim: To assess patient satisfaction with the SIMPLE Asthma IT Platform (SAP) for
Medicines Use Reviews in community pharmacies in the East of England.
Method: We compared patient satisfaction with MURs conducted with patients
who had asthma as well as those who did not. A validated 12-item MUR
patient satisfaction questionnaire (5 response options: Strongly Agree to
Strongly Disagree) was distributed by two participating community pharma-
cies for patient completion and return during late February to April 2016; 40
questionnaires were provided to one pharmacy to distribute and 20 to the
other. On receipt of completed questionnaires, individual scores given for each
item were summed, with a score of 60 indicating maximum MUR patient
satisfaction. These were compared between the two groups of patients
(asthma vs. no asthma) using analysis of variance.
Results: A total of 26 questionnaires were returned (43% response rate).
A comparison of total scores revealed that patients with asthma (n= 11) were
marginally more satisﬁed with their MUR service (mean satisfaction score 52,
standard deviation 8) compared to those (n= 15) without asthma (mss 50,
SD 8). This difference was not statistically signiﬁcant because a low effect size
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(0.15) would have required a sample size of 420 participants for sufﬁcient
power to detect statistically signiﬁcant differences.
Conclusion: Patients with asthma were potentially more satisﬁed with the MUR
service which used the SAP compared to those who did not have asthma for
whom the service involved practice as usual. This hints at an improvement in
the quality of the MURs delivered using the SAP. A larger sample size is
needed to verify these ﬁndings.
Conﬂicts of interest: None.
Funding: None.
Corresponding author: P Donyai
Email address: p.donyai@reading.ac.uk
34. “It lifts your spirits and you come away feeling lighter” -
patient experience of British Lung
Foundation singing groups
McKee H, Hopkinson N, Cave P, McDermott M
British Lung Foundation, London, UK
Brief outline of context: Small randomised controlled trials in secondary care1,2
have raised interest in singing as a possible strategy.
Outline of problem: Strategy to improve health status in people with chronic
respiratory disease. The aim of this evaluation was to understand patient
motivation and experience as part of a program of developing singing groups
undertaken by the British Lung Foundation (BLF), a UK charity for supporting
people with lung disease.
Strategy: The BLF trained 10 singing leaders to establish and deliver group
singing classes for people with lung disease recruited from the community.
Participant (mean age 70, 75% female) diagnoses were; 58% COPD, 34%
chronic asthma, 8% bronchiectasis. 18 individuals from 3 out of 10 of these
pilot groups were interviewed.
Measurement of improvement: We employed validated questionnaires to
measure physical, psychological and general wellbeing outcomes in pilot
participants. These questionnaires were disseminated at baseline, 3 months
and are to be disseminated at 6 month intervals. Our evaluation has shown
that participants maintained their physical and psychological functionality over
the ﬁrst three months. This is welcomed given the expected declines in
functionality seen in patients with COPD.
Effects of changes: Our evaluation has shown that participants maintained their
physical and psychological functionality over the ﬁrst 12 weeks. Further our
qualitative feedback revealed they experienced a multitude of physical and
psychological beneﬁts of singing including improved quality of life, reduced
depression, improved social health and having less exacerbations and medical
visits.
Lessons learnt: The main reason reported for taking part was to improve lung
condition but social aspects were also important. Respondents were
overwhelmingly positive about the experience and valued both the singing
itself and the breathing exercises and relaxation techniques that were taught.
As well as immediate improvements in mood associated with attendance,
participants also felt that the classes had improved their day to day quality of
life. Participants were themselves eager to promote singing as a useful activity
with some already volunteering to put up posters in local clubs or at their GP's
surgery. These data extend previous hospital-based studies to show that
singing classes are perceived as an effective and valued intervention by
participants recruited in a community setting.
Conﬂicts of interest: None.
Corresponding author: Heather McKee
Email address: heather.mckee@blf.org.uk
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35. Development of a whistling facemask for young children
Sanders MJ, Bruin R, Tran CH
Clement Clarke International Ltd, Harlow, UK
Aim: In a previous study of 24 volunteers aged 1.6-9.2 years, a valved holding
chamber (VHC) facemask incorporating an audible inspiratory ﬂow rate whistle
was used successfully by children 43.0 years (Po0.05).1 In this study, we
compare the in vitro aerosol performance of Ventolin Evohaler® via the
whistling facemask with the corresponding non-whistling facemask used in
conjunction with the VHC Able Spacer-2®.
Method: The facemasks were compressed via the study rig to a representative
paediatric use-volume (63mL) and ﬁve replicate aerosol actuations per mask
were prepared, assessed and analysed with the Next Generation Impactor
(NGI) employing standard procedures.
Results: The in vitro aerosol distribution proﬁles and performance parameters
for salbutamol aerosol were similar, irrespective of facemask type. The
whistling and non-whistling facemasks gave similar NGI particle size
distributions for all elements; the Spacer, facemask, ‘face’ (rig board), induction
port, stages 1-7 and MOC; with the majority of drug recovered from the Spacer
and from stages 3,4,5 and 6 (D50 stage particle diameters at 30L/min,
3.99-0.83μm). Key aerosol parameter data (mean± SD) for the whistling and
non-whistling facemask, respectively, were: metered dose 100.4 ± 7.0μg and
95.0 ± 5.7μg, emitted dose 86.4 ± 6.1μg and 82.7 ± 5.7μg, ﬁne particle fraction
(%o5μm) 46.1 ± 3.5 and 48.5 ± 4.2, and ﬁne particle dose (o5μm)
39.9 ± 5.4μg and 40.3 ± 5.7μg.
Conclusion: Integral whistles on VHCs are frequently compromised by aerosol
resistance properties2 and user misunderstanding.3 The information we have
to date indicates that a whistle located on the facemask is patient-friendly—
particularly important for young children—and does not affect the drug
aerosol.
Conﬂicts of interest: MJS and RB are employees of Clement Clarke International
which provided study funding.
Corresponding author: Mark Sanders
Email address: msanders@clement-clarke.com
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36. Use and misuse: salbutamol through an emergency spacer
device
Sanders MJ, Bruin R, Tran CH
Clement Clarke International Ltd, Harlow, UK
Aim: The single-use valveless DispozABLE Spacer™ has shown aerosol in vitro
characteristics that (i) are comparable to the rigid re-useable valved holding
chambers (VHCs) (28L/min), (ii) superior to the OptiChamber® Diamond VHC
and the disposable LiteAire® VHC1 at paediatric ﬂow rates (12L/min), and (iii)
surpass Ventolin® without a VHC following a one-second delay between
actuation and function measurements.2
Method: In this study, the effects on delivered dose of simultaneously exhaling
through the DispozABLE Spacer during actuation with Ventolin Evohaler® (i.e.
simulating poor co-ordination) was determined with Dose Unit Sampling
Apparatus (DUSA). A volume-limited 1L Vitalograph calibration syringe was
used to simulate the 160mL tidal exhalation of a young patient, with
DispozABLE Spacer and Ventolin Evohaler® without exhalation as control (n= 5
replicates).
Results: Salbutamol recovery with and without (control) simulated exhalations,
respectively, were: metered dose 82.3 ± 7.8μg and 94.7 ± 3.3μg, emitted dose
63.9 ± 7.3μg and 81.3 ± 3.8μg, actuator recovery 18.4 ± 2.2μg and 13.3 ± 0.7μg,
Spacer recovery 54.7 ± 7.5μg and 64.8 ± 5.6μg, and DUSA recovery 9.2 ± 3.0μg
and 16.6 ± 3.8μg. Simulated exhalation therefore reduced DUSA recovery
by 44%.
Conclusion: We have described a validated methodology which involved a 2-
second connection/disconnection to a syringe for both test (operated) and
control (not operated) evaluations. Methodological recovery losses will have
occurred that prevent correlation with routine testing; the DUSA dose
during simulated exhalation relative to DUSA dose in normal use being the
key data. These data demonstrate a reduction of nearly one-half but indicate
that in sub-optimal use, mimicking an emergency or poor patient
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coordination, the young patient could receive a suitable dose via the
DispozABLE Spacer.
Conﬂicts of interest: MJS and RB are employees of Clement Clarke International
which provided study funding.
Corresponding author: Mark Sanders
Email address: msanders@clement-clarke.com
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37. Keeping respiratory patients active post pulmonary
rehabilitation
Green A, McKee H, Hobbs J
British Lung Foundation (BLF), UK
Brief outline of context: Due to a lack of available places for respiratory patients
on existing post pulmonary rehabilitation maintenance exercise classes in
Portsmouth the BLF successfully secured funding from Portsmouth Clinical
Commissioning Group (CCG) via Breathe Easy Portsmouth South to deliver
2 extra maintenance exercise classes to meet this demand.
Outline of problem: Patients with chronic obstructive pulmonary disease
(COPD), interstitial lung disease (ILD) and bronchiectasis attended these classes
which were delivered by Band 4 and Band 3 Physiotherapy Technicians from
Solent NHS Trust.
The British Thoracic Society (BTS) Guideline on Pulmonary Rehabilitation in
Adults concludes that “continuation of supervised exercise training beyond
pulmonary rehabilitation protects the patient from a decline in exercise
capacity compared with a control group” and recommends that “all patients
completing PR should be encouraged to continue to exercise beyond the
programme”. Maintenance programmes help people with lung disease to
sustain their exercise capacity over the short to medium term . Therefore in
order for patients to be able to maintain their wellbeing they needed to be
able to access maintenance exercise classes. (a) 2 classes successfully delivered
between March 2015–March 2016; (b) a total of 103 different patients
attended more than 1 exercise session from the 2 maintenance classes over
the year; (c) of these patients were new to the classes and (d) of these 55
patients 56% of them completing 6 weeks of their 12 week course.
Measurement of improvement: Attendance at the maintenance exercise classes
has delivered either a continuum in breathlessness levels or in the majority of
cases there has been an overall improvement in breathlessness levels and
improved exercise tolerance. This has included: (a) of those patients who
completed the classes 54% have continued to improve their distances walked
from starting pulmonary rehab, completing the 7 week programme and then
completing the 12 sessions at their local maintenance class; (b) 63% of patients
have increased their distance between ﬁnishing pulmonary rehab and
completing the 12th session of the maintenance exercise class.
 68% of the patients have improved there distances walked comparing with
their initial assessment and 12th session at maintenance.
 There have also been instances where 2 completer patients have increased
their walking distances up to 83% and 120%! This is showing a great
improvement and a maintained amount of ﬁtness from their ﬁrst initial
assessment prior to any exercise intervention.
Effects of changes: We measured the impact of long term lung conditions on
the patients’ lives and how this has changed over attending the exercise
classes via the COPD Assessment Test (CAT score), the Hospital Anxiety and
Depression Score (HAD), and the Dyspnoea section of the Chronic Respiratory
Disease Questionnaire (CRDQ) to measure the patients quality of life/well-
being. See below for results: CAT score
 42% of the patients had improved or maintained their scores achieved after
completing their original pulmonary rehabilitation class to completion of the
maintenance exercise class.
 63% have improved or maintained their scores from their initial assessment
prior to starting pulmonary rehabilitation to completion of the maintenance
exercise class.
HAD score
 79% of those patients who completed the maintenance exercise class had
shown improvements on their HAD score upon completion of the original
pulmonary rehabilitation class.
CRDQ Dyspnoea
 42% of the patients had improved or maintained their scores achieved upon
completion of the original pulmonary rehabilitation class.
 92% of the patients had improved or maintained their scores from their
initial assessment prior to starting pulmonary rehabilitation.
Lessons learnt: The involvement and attendance of members from BLF Breathe
Easy Portsmouth South (patient self-help support group) has been invaluable
to the numbers of people attending and completing the classes. Breathe Easy
input via peer support, encouragement and leadership has been a pivotal
factor in ensuring the maintenance exercise classes have been fun (being
breathless & exercising isn’t always fun!) and that patients continued to
regularly attend the classes.
There is real desire from the patients who have attended and beneﬁted from
pulmonary rehabilitation to be able to continue exercising in a supervised and
structured environment. The ﬁndings show that all of the patients who
attended the maintenance exercise classes have continued to make
improvements in one or more of their outcome measures (breathlessness
levels & exercise tolerance, and/or quality of life measures) demonstrating
positive patient outcomes.
Conﬂict of interest: None.
Funding: Portsmouth Clinical Commissioning Group – Public Sector Challenge
Fund for the voluntary & community sector.
Corresponding author: Ashley Green
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38. Innovative approach to COPD improves disease impact,
quality of life and reduces hospital admissions in Glasgow
Milligan M, Marshall S, Marshall S, Anderson D
National Health Services (NHS) Greater Glasgow and Clyde, UK
Aim: The risk of COPD is 44% higher for patients in Glasgow than the rest of
Scotland and accounts for 44, 000 emergency annual bed days. A Specialist
multidisciplinary Community Respiratory team was introduced to provide an
alternative pathway to hospital admissions for exacerbations in patients with
severe COPD and to decrease length of hospital stay. The team adopted a
person centred approach with goal setting to facilitate conﬁdence and
knowledge in self management.
Method: A pre and post intervention observational study was performed using
validated measures of impact: (1) COPD Assessment Tool (CAT) -a measure of
impact of disease, (2) EQ5DL- a measure of quality of life. Semi structured
telephone interviews of 58 patients.
Results: A total of 266 patients completed an intervention, 63% were female;
mean age 72, 88% had a MRC of 4 or 5, 60 % of patients from the lowest
deprivation quintile. Mean input: 8 sessions over 8 weeks. Quantitative analysis:
A Paired sample T test on CAT score showed a signiﬁcant improvement
(P= 0.001) with an mean change of 6. A Paired sample T test on EQ5DL
showed signiﬁcant improvement (Po0.001). 6 patients stopped smoking.
There was 85% achievement of goals. There was a 60%reduction in hospital
admissions one year post intervention.Qualitative analysis demonstrated
increased conﬁdence and improved knowledge to self manage particularly
during exacerbations. Patients also reported heightened activity levels,
resulting in being less housebound.
Conclusion: This pilot study was not a randomised controlled study, but
demonstrated improved health outcomes in patients with severe COPD from
deprived areas using a community person centred model. It may also have an
impact on hospital admissions. Future work with control groups is planned.
Conﬂicts of interest: None.
Funding: Funding for the Project for 2 years through Scottish Government
Change Fund.
Corresponding author: Marianne Milligan
Email address: Marianne.milligan@ggc.scot.nhs.uk
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39. Integrating Smoking Cessation
Preston WJ
George Eliot Hospital, UK
Brief outline of context: Beneﬁts of developing a Stop Smoking service as part of
a respiratory team and then creating sustainability by integrating into the
development of an ambulatory care team that facilitates smoking cessation as
part of a range of pathways.
Outline of problem: We recognised the importance of smoking cessation as a
respiratory treatment. In 2010 we won a 3 year tender to facilitate a service
and needed to ensure this was sustainable and to integrate to allow ﬂexibility
both in terms of 7 day cover and across primary/ secondary care boundaries.
Obtaining funding
Sustainability
Smoking cessation being seen as a treatment
Flexible service with minimal costs & community provision
Strategy: Tender to provide community smoking cessation in the neighbour-
ing PCT. This funding was utilised to fund a full time stop smoking adviser and
we upskilled one of our respiratory team support workers. A range of
respiratory MDT became qualiﬁed advisers to increase reach and integrate
service. Became provider for our local stop smoking service and when the
PCT's where devolved the community service became part of our trust. We
developed a Public Health strategy and ensured smoking cessation is included
in all pathways and documents, becoming a smoke free site in 2016.
Medication is available in all area's and the smoke free site strategy has
stregnthened this with a local protacol for prescribing. When we developed
our respiratory support service into an ambulatory care unit (that is the GP
interface for medicine) we ensured all staff could be trained as stop smoking
advisers to provide a 7 day service. The stop smoking adviser is part of this
team also which gives a very cost effective and sustainable service that can
follow up patients/ carers/ staff/ public for a full 12+ treatment.
Measurement of improvement: We have integrated measurements with an
ambulatory quality dashboard and share the community service database
regarding smoking cessation.
Effects of changes: The respiratory team champion smoking cessation as a
treatment and as British Thoracic Society (BTS) Stop Smoking Champion I have
found it easier to achieve change. By applying for a 'any willing provider'
tender we gained an initial funding stream which allowed service
development and then by collaborating and integrating we have achieved
a very ﬂexible and cost effective service for patients and the wider community.
Lessons learnt: Plan for sustainability from the start of a project
Upskill existing staff - much easier to embed change
Having smoking cessation as a treatment/ pathway helps
integrate into 'normal' service and being part of community provision helps
sustainability
With recent Public Health cuts having smoking cessation woven into many
systems and pathways would make stopping the service noticable
smoking cessation is the most important treatment for current smokers.
A full National Health Services (NHS) stop smoking service should be available
accross the health economy and we should not under estimate the positive
effect health care professionals can have to prompt a quit attempt.
Education grants, Speaker payments -various pharma
Vice-Chair of ARNS
Funding: None.
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40. Optimising outcomes in asthma and COPD: consensus-
driven recommendations for future service development
Baskaran L, Dunford C, Gwynn S, Khambh J, Ledson M, Prigmore S,
Scullion J, Warren T
Baskaran L on behalf of consensus steering group
Aim: In the UK, premature mortality from COPD is almost twice and asthma
over 1.5 times the European average. Earlier diagnosis may reduce morbidity
and improve quality of life. This project identiﬁes differences in the
perceptions of various stakeholder groups regarding effective outcome
improvements in asthma and COPD and offers 10 key recommendations for
optimising outcomes in asthma and COPD.
Method: In meetings sponsored by Teva, a group met to deﬁne consensus
statements, subsequently tested by questionnaire. A Delphi consensus
methodology was used to assess levels of agreement with each statement.
Respondents included health care professionals across a range of specialties at
UK meetings sponsored by Teva between June 2015 and January 2016.
Results: A total of 184 respondents completed questionnaires. A total of 24 out
of 42 statements (57.0%) exceeded the agreement threshold (466.0%) and
are thus regarded as validated by the respondents. Differences were seen
between care settings, with primary care commonly indicating lower levels of
agreement than their secondary care colleagues.
Conclusion: Most respondents indicate that it is possible to deliver effective
care across all care settings with a need for further development of locally
integrated care. Clear deﬁnition of appropriate outcomes will support value-
based care models and thus effective integration of care. Primary care
respondents agree that healthcare professionals (HCPs) should seek products
with the lowest acquisition cost where there is clinical equivalence (75.0%).
The need for branded prescribing of inhaler therapies in asthma and COPD to
ensure patient safety and support device familiarity is recognised. Clear referral
pathways will support patient care (69.8% agreement) with the MDT being
available in the same building.
Conﬂicts of interest: None stated.
Funding: Teva initiated and funded this project, which was independently
facilitated by Triducive Ltd. Teva had no editorial input, but did review the
material for factual accuracy.
Corresponding author: Lavan Baskaran
Email address: lavan.baskaran@nhs.net
41. Bridging the smoke free gap: A collaborative measure to
meet health improvement needs of people with severe COPD in
Glasgow
Milligan M, Sim M, Hunter S, Sherwood L, Mulhall L, Marshall S,
Preece R, Smith A
National Health Services (NHS) Greater Glasgow and Clyde, UK
Aim: The risk of COPD is 44% higher for patients in Glasgow than the rest of
Scotland. Smoking cessation is the single most effective and cost effective
therapy and can provide access to long term oxygen therapy. Specialist
smokefree services are traditionally located in clinics, however due to physical
limitations resulting in being house bound, patients with severe COPD were
unable to access this. This collaborative, person-centred approach between
the Community Respiratory Team and the Health Improvement Team
remedies this.
Method: The Community Respiratory Team (CRT) supports patients with severe
COPD within the home setting to improve self management and enhance
physical activity. The CRT identiﬁed patients who were unable to access smoke
free services outside the home and demonstrated motivation to quit. A joint
review was carried out between the health improvement practitioner and the
CRT clinician within the patients home. Motivation to quit & previous attempts
were discussed. Individualised care plan including relevant GP/ pharmacy
liaison produced. Ongoing support by telephone or 1:1 by the health
improvement practitioner and ongoing CRT interventions.
Outcome measures: 4 & 12 week quit rates, Carbon Monoxide Measures,
qualitative analysis.
11 patients have been supported through the service so far.
100% demonstrated high willingness to quit & good engagement levels.
Patients reporting greater beneﬁt with direct contact than by telephone only
advice.
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50% set a quit date, compared to 20% of local specialist service GP referrals.
Early indicators demonstrate heightened levels of smoking cessation success
than previous system (telephone only advice). Providing a collaborative effort
with specialist services within the home can beneﬁt health outcomes for
patients with severe COPD.
Conﬂicts of interest: Nil.
Funding: The Community Respiratory Team is funded through Scottish
Government Integration Care Fund.
Corresponding author: Marianne Milligan
Email address: Marianne.milligan@ggc.scot.nhs.uk
42. PLEASANT: Preventing and lessening exacerbations of
asthma in school-age children Associated with a New Term – A
Cluster Randomised Controlled Trial and economic evaluation
Julious SA, Horspool M
University of Shefﬁeld, UK
Aim: Asthma episodes are known to be seasonal. Reports have shown peaks in
asthma episodes in school-aged children associated with the return to school
following the summer vacation. A drop in prescription collection in August has
been observed which is associated with an increase in the number of
unscheduled medical contacts after the return to school in September.
Method: Cluster randomised trial with health economic analysis.
Setting: Primary care. Participants: School aged children aged 5-16 with
asthma.
Interventions: A letter sent, from the GP to parents/carers of school-aged
children with asthma, prior to the start of school summer holidays, reminding
them of the importance of taking their medication and to ensure they have
sufﬁcient medication prior to the new school year starting. The control group
was usual care.
Primary outcome: proportion of children who had an unscheduled contact in
September 2013. Supporting endpoints included the proportion of children
who collected prescriptions in August and unscheduled contacts through the
following 12 months.
Results: For unscheduled contacts in September there is no evidence of effect:
the odds-ratio was 1.09 (95% CI 0.96 to 1.25) against the intervention. The
intervention did increase the proportion of children collecting a prescription in
August (odds-ratio 1.43; 95% CI 1.24 to 1.64) as well as scheduled contacts in
the same month. For wider time intervals (Sep-Dec 2013 and Sep-Aug 2014)
there is evidence the intervention reduced contacts. The economic analysis
estimated a high probability that the intervention was cost saving. There was
no increase in quality-adjusted life-years.
Conclusions: The intervention succeeded in increasing prescriptions collected
in August as well as increasing scheduled contacts in August. The intervention
did not reduce unscheduled care in September but after September there is
evidence in favour of the intervention. The reduction in medical contacts lead
to a favourable impact on costs.
Conﬂicts of interest: None.
Funding: The research reported in this abstract was funded by the Health
Technology Assessment (HTA) programme as project number 11/01/10.
Corresponding author: Steven Julious
Email address: s.a.julious@shefﬁeld.ac.uk
43. Implementing improved asthma self-management as
routine treatment (IMP2ART)
Daines L, Morrow S, Wiener-Ogilvie S, Taylor SJC, Pinnock H on behalf
of IMP2ART team
University of Edinburgh, UK
Aim: Supported self-management for asthma, which is a cost effective
intervention that reduces unscheduled care and improves asthma control, is
poorly implemented in routine clinical practice. The IMP2ART study aimed to
explore the perspectives of health care professionals (HCPs) providing, and
patients using supported self-management, on the best way to embed self-
management into routine asthma care.
Method: Recruitment of participants from 10 general practices across the UK
started in March 2016. Data were collected from individual interviews and
focus groups. Audio recordings were transcribed and analysed thematically.
Results: Data collection is on-going. Early data (from the ﬁrst 10 patients)
identiﬁed individualised education at the time of diagnosis as important in
understanding why and how to self-manage. Experienced patients reported
learning intuitively how to self-manage over years; reducing the value they
placed on a written asthma action plan.
Emerging themes from 10 HCPs (4 interviews; 6 in a focus group) identiﬁed
improved access to and use of asthma action plans, personalisation of asthma
templates and better accessibility to clinical updates and education as factors
they felt would enable self-management to become a routine part of
asthma care.
Conclusion: Patients regarded personalised care most highly: at the time of
initial diagnosis and during their regular review. HCPs seek greater availability
of resources and education and integration with their electronic health record.
Data from this qualitative study will inform the development of a whole
systems approach to embedding optimal asthma self-management in
routine care.
Conﬂicts of interest: None.
Funding: Programme development grant funded by the National Institute for
Health Research.
Corresponding author: Luke Daines
Email address: luke.daines@ed.ac.uk
44. What drives initial inhaled corticosteroid prescribing
decisions in newly diagnosed COPD? A Clinical Practice
Research Datalink (CPRD) study
Chalmers JD, Tebboth A, Gayle A, Ternouth A, Ramscar N
Ninewells Hospital and Medical School, Dundee, UK
Aim: GOLD guidelines for COPD do not recommend inhaled corticosteroids
(ICS) as initial therapy for COPD patients in GOLD stage A or B. Nevertheless, in
clinical practice initial use of ICS is common. This study investigated predictors
of ICS use in newly diagnosed COPD patients in the UK.
Method: This is a retrospective descriptive cross-sectional study using the UK
Clinical Practice Research Datalink (CPRD). The patient cohort included people
with a new diagnosis of GOLD category A or B COPD registered at a CPRD
practice between June 2005 and June 2015. Patients initially prescribed an ICS
containing regime were compared with those receiving bronchodilators
without ICS (non-ICS group).
Results: A total of 29,815 patients with spirometry-conﬁrmed COPD were
identiﬁed in the study. The average age was 67 years and 54% were male.
Overall, 63% of those treated with maintenance therapy in the ﬁrst three
months after diagnosis were prescribed ICS-containing therapy vs. 37%
prescribed non-ICS therapy, although ICS prescribing reduced over the study
duration (from 77% in 2005 to 47% in 2015). The strongest predictors of ICS
use were concurrent diagnosis of asthma (OR: 3.49; Po0.0001) and
geographical region (Po0.0001). When concurrent asthma patients were
excluded, region remained a statistically signiﬁcant predictor (Po0.0001).
Other signiﬁcant predictors included GP practice, younger age and co-
prescription with short-acting bronchodilators (po0.0001).
Conclusion: ICS prescribing is common in GOLD A/B patients, and is more likely
to be determined by regional variation in prescribing practices than by patient
characteristics.
Conﬂicts of interest: JC has received funding from Boehringer Ingelheim (BI).
AbT, AG, AnT and NR are employees of BI.
Funding: The study was funded by Boehringer Ingelheim.
Corresponding author: James Chalmers
Email address: jchalmers@dundee.ac.uk
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45. Tailored intervention for anxiety and depression
management (TANDEM) in COPD: protocol for a randomised
controlled trial
Taylor SJC, Sohanpal R, Pinnock H on behalf of the TANDEM
investigators
Barts and The London School of Medicine and Dentistry, Queen Mary University of
London, UK
Rationale: The National pulmonary rehabilitation (PR) audit revealed only 42%
of those referred to PR complete a course. Attendance/completion rates are
especially poor in people with anxiety/depression.
Aim: To reﬁne, pilot and evaluate a tailored, psychological intervention which
immediately precedes, and optimises the beneﬁts of, routine PR. The
overarching aim is to reduce mild/moderate anxiety and/or depression in
people with moderate or severe COPD.
Method: Tailored intervention for anxiety and depression management
(TANDEM) is a tailored, one-to-one, domiciliary/ clinic-based, psychological
intervention with an emphasis on managing breathlessness. It is based on
cognitive behavioural approaches, The Lung Manual for anxiety (Heslop-
Marshall) and COPD SPACE (Singh) for practical COPD advice. It is delivered by
trained respiratory health professionals supervised by a clinical psychologist.
Participants will be recruited from primary/secondary care and PR services.
PRE-PILOT developmental work (on-going),
PILOT RCT and PROCESS EVALUATION to inform: the feasibility of delivering
the intervention and trial processes. We will randomise 45 patients across two
sites (London and Leicester). If no protocol changes are required we will
proceed immediately to a full-scale trial.
FULL SCALE TRIAL of the intervention across four sites in London and The
Midlands (December 2018 to April 2020). Co-primary outcomes are anxiety
and depression at 6 months. We will recruit 430 participants in total and follow
them up for 12 months. We will conduct a full economic evaluation alongside
the effectiveness study.
Results: We describe a study protocol.
Conclusion: If successful the intervention is likely to change the way PR is
delivered.
Conﬂicts of interest: None.
Funding: This project was funded by the National Institute for Health Research
Health Technology Assessment (HTA 13/146/02) The views and opinions
expressed therein are those of the authors and do not necessarily reﬂect those
of the HTA, NIHR, NHS or the DH.
Corresponding author: Steph Taylor
Email address: s.j.c.taylor@qmul.ac.uk
46. Signs of breathlessness: integrated case-ﬁnding project
Longstaff J, Matheson C, Dominey R, Brown V, Roberts C, Lanning E,
Chauhan AJ
Portsmouth Hospital Trust, Wessex Academic Health Science Network (AHSN) and
National Health Services Improving Quality (NHS IQ), UK
Brief outline of context: Breathlessness is one of the most common symptoms
in the UK 43.5% of acute admissions and causes signiﬁcant impact on hospital
utilisation.1
Outline of problem: Despite patients consulting for years with
respiratory symptom, they are often diagnosed several years later or
not at all.2
Breathlessness is overlooked and has no core funding. A generic approach to
provide early diagnosis would be highly beneﬁcial.
Strategy: Patients were identiﬁed with breathlessness symptoms, but no
diagnosis, using GRASP case-ﬁnding suite tools of in primary care. They were
invited to attend ‘carousel’ practice clinics run by specialist respiratory
secondary care MDTs working in partnership with primary care healthcare
professionals (HCPs) resulting in same day accurate diagnosis and patient
education.
Measurement of improvement: Percentage of patients diagnosed, treatment
adherence, exacerbations, ED attendance, OOH visits, acute hospital admis-
sions and patients feedback. Out of 42 patients reviewed: 97.2% were given a
conﬁrmed respiratory diagnosis resulting in an 89% reduction in exacerba-
tions, 100% in acute hospital admissions, OOH and ED visits. Patients had
greater conﬁdence in managing symptoms and 100% would recommend the
clinic.
Lessons learnt: Case- ﬁnding by symptoms rather than condition provides an
extremely high diagnosis yield, health beneﬁts and reduced healthcare care
costs. Evaluating HCP training would be beneﬁcial. Cost per patient of
specialist clinic is £142 compared to £242 for respiratory multi-professional
outpatient appointment. Specialist MDT working alongside primary care HCP’s
increased the skill level to diagnose accurately patients with breathlessness
symptoms.
Conﬂict of interest: None. Funded by National Health Services Improving
Quality (NHS IQ).
Funding: None.
Corresponding author: Jayne Longstaff
Email address: Jayne.longstaff@porthosp.nhs.uk
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47. Getting transition right for Young People (YP) with Asthma
Liu N, Datt C, Moreiras J
Whittington Hospital, London, England
Outline: Transition from paediatric to primary or hospital care is a challenging
but inevitable step for young people (YP). A structured transition programme
promotes YP’s relationship with GP/hospital team, potentially improving
health outcomes.
Outline of problem: Whittington Health Asthma Service transitions about 10 YP
a year to GP/adult services. Paediatric care promotes dependence whereas
adult services encourage independence, which is relative to patients’
knowledge and attitude. Poor asthma understanding and anxiety can
adversely affect management following transition to adult services.
Assessment: Previous transition clinics attendance and patient engagement
were poor; these were offered to YP transitioning to hospital teams but
not GPs. Pre-transition surveys showed anxieties mainly surround
non-medical needs.
Strategy: A transition kit was developed, including transition pathway,
information packs, healthcare checklist and transition passport. Literature
highlights transition should incorporate holistic life skills besides medical
needs. A transition workshop was trialled; incorporating question-and-answer
sessions for YP and parents separately, allowing them to meet the adult team
and learn about asthma management.
Measurement of improvement: Compared to transition clinics, the workshop
had better attendance and engagement. Our post-workshop survey showed
improved anxiety levels for YP but worsened for parents. Everyone found the
workshop beneﬁcial. They understood asthma care better, including how to
arrange appointments and prescriptions. The workshop’s impact will be
assessed by quantifying adult services drop-out rates.
Lessons learnt: The synergy of YP and parents as a group gave them
conﬁdence to be vocal. We will continue bi-annual workshops, ideally
involving GPs and adult teams.
Message for others: Adolescents appreciated meeting the teams informally,
enabling them to understand transition. Parental anxieties, which featured
greatly, should be addressed.
Conﬂict of interest: None.
Funding: Whittington Health National Health Services Trust.
Corresponding author: Norrice Liu
Email address: norricemary.liu@nhs.net
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48. Is in-situ simulation training effective a community
environment? An evaluation of the acute COPD Early Response
Service (ACERs) Simulation Training Programme.
Graham L, Kenward A, Dimmock V
Homerton University Hospital, UK
Outline: Simulation training is effective in improving patient care, clinical and
non-clinical skills, identifying latent safety threats and improving quality in
practice. In-situ simulation training provides opportunities for multi-disciplinary
training, facilitating team working and communication skills in a real life
environment.
Outline of problem: In comparison to a simulation suite, training in the
community environment can be challenging and often disrupt clinical
practice.
To evaluate if a community simulation training program can be run effectively
and is beneﬁcial to staff.
Strategy: Simulation sessions were held between July 2015 and May 2016 in a
community setting in City and Hackney. Scenarios were based on real clinical
situations, where it was felt learning could be gained. All sessions were
attended by the ACERs MDT, physiotherapists, nurses and psychologist,
rehabilitation assistant and students.
Measurement of improvement: All attendees were asked to complete a self-
reported, locally developed evaluation measure. This measured inﬂuence on
clinical practice and allowed staff to report on how the session had done so.
Effects of changes: All 100% of participants ‘agreed’ or ‘strongly agreed’
simulation training inﬂuenced their clinical practice. Staff reported feelings of
empowerment, improved conﬁdence in managing difﬁcult conversations or
complex situations, identiﬁcation of knowledge gaps, as well as action points
to improve safety and communication skills.
Lessons learnt: Clinical action points were learnt, such as, need for easy
identiﬁcation of rescue medication when providing telephone support to
patients. The ACERs simulation training programme, emphasised human
factors skills which as part of the hidden curriculum that can’t be taught,
providing a platform for further discussion and learning. This audit has
demonstrated that simulation training can be run effectively in a community
environment, with minimal disruption to clinical practice.
Conﬂict of interest: Nil.
Funding: None.
Corresponding author: Laura Graham
Email address: Laura.Graham@homerton.nhs.uk
49. An audit to gain more understanding of current spirometry
practice in City and Hackney General Practice
Gyansa J, Hodson M, Graham L
Homerton University Hospital, UK
Outline: To improve the quality of spirometry in practice in City and Hackney.
Audit of current practice. Variety existed, but no current data or information to
conﬁrm this observation.
Assessment: Locally developed questionnaire, was sent to 43 GPs practices
between August and November 2015. Response rate was 63% (n= 27/43).
A total of 52 medical or health professionals regularly practice spirometry, 73%
(n= 38) were nurses, 2% GPs (n= 1) and 25% Health Care Assistants (HCA)
(n= 13). At 96% (n= 26) of practices interpretation occurred by a member of
staff who did not perform the original test, normally a GP (62% [n= 16]). A total
of 33% (n= 17) of staff had received no training in the practice of spirometry.
Of the 35 staff who had received some form of training, 14% (n= 5) were
internally trained by their colleague. 66% of staff trained, had been trained
within the last 2 years (n= 22), 17% (n= 6) within 4 years and 23% (n= 8)
within 5 years.
Strategy: As part of the larger project, members of the respiratory team (ACERs)
worked directly with practices to improve the quality of spirometry practiced
and ensure staff received training.
Measurement of improvement: This audit was part of a larger ongoing project.
Effects of changes: Currently not measured.A wide variety of spirometry
practice exists in City and Hackney. Staff performing spirometry, did not always
interpret results, potentially impacting on the diagnosis and management.
Training was inconsistent and not always regular, with a third of staff untrained
or unqualiﬁed to practice spirometry. Must ensure quality of spirometry
performed in primary care follows national guidelines and anyone practicing
spirometry has appropriate and regular training.
Conﬂicts of interest: Nil.
Funding: Funding for back ﬁll staff involved by City and Hackney Clinical
Commissioning Group.
Corresponding author: Jane Gyansa
Email address: Jane.Gyansa@homerton.nhs.uk
50. Acid-suppressive medications during pregnancy and risk of
asthma and allergy in children: a systematic review and meta-
analysis
Devine RE2, McCleary N2, Sheikh A2, Nwaru BI3
1University of Edinburgh, UK; 2NHS Borders, UK; 3University of Tampere, Finland
Aim: Synthesise and interpret the evidence on the association between
maternal prenatal use of acid-suppressive medications and asthma and allergy
risk in children.
Method: A systematic review and meta-analysis of observational epidemiolo-
gical studies (cohort, case-control, and cross-sectional studies) was conducted.
Eligible studies investigated women taking acid-suppressive medications
during pregnancy and their children aged ≤ 17 years. Eleven electronic
databases were searched from inception to the end of 2015. Databases of
ongoing studies and reference lists of included studies were searched, and
experts in the ﬁeld were contacted. Two reviewers independently screened all
records, extracted data, and assessed the risk of bias within studies using the
Effective Public Health Practice Project (EPHPP). Disagreements were arbitrated
by a third reviewer. Random-effects meta-analyses were conducted to
synthesise the data. The Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) approach was used to evaluate the quality of
the overall evidence base.
Results: The search retrieved 3282 records of which eight (enrolling 1,620,043
participants) met inclusion criteria. All were judged to be of high (n= 6) or
moderate (n= 2) quality. In the pooled analysis, maternal use of any acid-
suppressive medication (RR 1.36, 95%CI 1.16-1.61), H2-receptor antagonists (HR
1.46, 95%CI 1.29-1.65), and proton pump inhibitors (HR 1.30, 95%CI 1.07-1.56)
were associated with increased asthma risk in children. Two studies which
examined other allergic diseases reported an increased risk amongst children
of mothers exposed to acid-suppressive medications.
Conclusion: Prenatal exposure to acid-suppressive medications is associated
with an increased risk of asthma in children. Research is now needed to
establish whether this is a causal relationship, or a result of residual
confounding and/or confounding by indication.
Conﬂicts of interest: None.
Funding: None.
Corresponding author: Nicola McCleary
Email address: nicola.mccleary@ed.ac.uk
51. Is it COPD? Using case discussion at multi-disciplinary team
(MDT) meetings to improve accurate diagnosis and appropriate
intervention and management of patients with chronic lung
disease
O’Neil S, Hope S, Ahmad N
Shropshire Community Health NHS Trust, UK
Outline: COPD is a major health problem worldwide. Telford and Wrekin has a
higher than national prevalence of COPD. An aim of our service is to provide
accurate diagnosis, specialist review and evidence based management
through a multidisciplinary community based service that will improve the
care of people living with COPD.
Outline of problem: There is much consensus on ﬁnding the ‘missing millions’
of COPD patients; however what is arguably more surprising is how COPD is
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often misdiagnosed or mismanaged. Many lung diseases share clinical and
functional similarities consequently causing misdiagnosis and/or mismanage-
ment playing an important role in the increase of mortality, morbidity and
quality of life experiences in this patient group.
Strategy: Patients were referred by a Respiratory Consultant, Respiratory
Specialist Nurses, Community Matrons and Respiratory Physiologists to be
discussed at an multi-disciplinary team (MDT) meeting bimonthly over a
12 month period. Further investigations, medication review and direct referrals
for instantaneous secondary care reviews were made as part of an ongoing
individualised care plan.
Measurement of improvement: A service evaluation made between 2014-2015
found that of a cohort of 65 patients, 31% of patients had treatment
optimised, 15% received an alternative respiratory diagnosis and a further 8%
were referred onto specialist centres for surgical interventions and
management.
Effects of changes: We now have an allocated Respiratory Nurse with every
local GP practice, to offer accessible specialist advice and enable links to the
multidisciplinary integrated service.
Lessons learnt: Community MDT meetings are an effective way to optimising
treatment, establishing accurate diagnosis and improving quality of patients
with COPD. It helps to enable links with primary care clinicians and achieve an
ideal integrated service for our patients Early detection and treatment of
correct diagnoses may improve long term prognoses and prevent irreversible
loss of lung function in patients with lung disease.
Conﬂicts of interest: None.
Funding: None.
Corresponding author: Stephanie O’Neil
Email address: stephanie.o’neil@nhs.net
52. Self-ﬁll oxygen systems - beneﬁts for patients, healthcare
providers and the environment
Murphie P, Hex N, Setters J, Little S
National Health Services (NHS) Dumfries and Galloway, UK
To explore the role and evidence base for 'Non-delivery' Home oxygen
systems that allow self-ﬁlling of ambulatory oxygen (AO) cylinders in people
with Chronic Lung disease. They may offer an unlimited supply of AO in
suitably assessed people who require Long term oxygen therapy (LTOT)
provided they can use these systems safely and effectively, allowing users of
LTOT to be self-sufﬁcient and facilitating longer periods of time away
from home.
Methods: A national review of the home oxygen service in Scotland was
conducted resulting in consolidation of all home oxygen delivery systems
under a single contractor with the transition to this new service delivered over
2013. A health economics analysis was conducted following the transition to
compare the differences between the previous conventional AO cylinder
delivery and the HomeFill (HF) system.
Results: Conservative calculations indicate a cost for 3 AO cylinders of about
€100 per week, or €5200 per year, compared with a cost for HF of €1100 per
annum, giving a beneﬁt of around €4000 for each patient. The costs savings
related to reduced travel and delivery in 1213 HF users compared to the AO
cylinder delivery model is 1.25million Km's and the estimated carbon emission
(CO2e) reduction for the HF system is 261.29 tonnes of CO2e.
Conclusion:Evidence is emerging that 'Self-ﬁll' / 'non-delivery' oxygen systems
can meet the AO needs of many patients using LTOT and can have a positive
impact on quality of life; increased time spent away from place of residence
and can offer signiﬁcant ﬁnancial savings to health care providers. Even with
conservative estimates in the health economics analysis, the provision of the
HF system to around 1000 patients saves about €2 million per year in Scotland.
Conﬂicts of interest: see below.
Funding: York Health Economics Consortium, University of York received
funding from Invacare for the Health economics anaysis work. This was
conducted after the National project was completed.
Corresponding author: Phyllis Murphie
Email address: Phyllis.murphie@nhs.net
53. Improving Secondary Care/Primary Care communication
using integrated multidisciplinary team meetings
Dalgliesh VK, MacNee W
Royal Inﬁrmary of Edinburgh, Edinburgh, UK
Outline: COPD is a major health problem world-wide, ranking ﬁfth for global
burden of disease. Managing exacerbations is a signiﬁcant source of COPD
health care expenditure.
Outline of problem: 10% of patients with COPD, who experience acute
exacerbations and hospital admissions, account for over 70% of COPD health
care costs. With limited health care resources, efﬁcient management involves
identifying patients most at risk of exacerbations and integrated management
between primary and secondary care.
Assessment: IT services available for Primary Care and Secondary Care are not
directly compatible. Secondary Care in National Health Services (NHS) Lothian
uses the TRAK system with TRAK Alerts that is not accessible in Primary Care.
Primary Care uses Key Information Summaries (KIS) which can be read by
Secondary Care and Community Care, but cannot be created in
Secondary Care.
Strategy: 1. Integrated multidisciplinary team meetings (iMDT’s) discussing high
risk patients identiﬁed by two or more hospital admissions within twelve
months. 2. Documenting TRAK Alerts to guide management during acute
admissions. 3. iMDT summaries sent to GP’s including TRAK Alert, to guide KIS
documentation and management in Community and Primary Care settings.
Measurement of improvement: A service evaluation identiﬁed all 252 high risk
patients managed in iMDTs, 90.1% had TRAK alerts (95% CI 85.8-93.2). 69.8%
had a KIS (95% CI 63.9-75.2). Comparing 495 patients in NHS Lothian with long
term conditions at high risk of hospital admission (SPARRA score 60+%), 61.2%
had a KIS (95% CI 56.8-65.4).
Effects of changes: Integrated multidisciplinary team meetings documentation
with alerts increased Primary Care documentation which encouraged effective
management between all hospital and community teams. iMDT documenta-
tion with speciﬁc recommendations to Primary Care to create or update
patients KIS can encourage effective communication and management within
hospital and community settings.
Proactive patient identiﬁcation and enhanced iMDT documentation can
improve communication between Community and Secondary care, improving
medical management and patient safety.
Conﬂict of interest: None.
Funding: None.
Corresponding author: Victoria Dalgliesh
Email address: vkbooth@hotmail.com
54. Improving care for patients with COPD using a care bundle
in primary care
Matthew D, Elkin S, Woodcock T, Chopra R, Armstrong S, Hamerton V
National Institute for Health Research Collaboration and leadership in applied
research and care NWL, UK
Outline: COPD is a common long-term condition characterised by breath-
lessness and acute exacerbations associated with hospital admissions and
poor quality of life.
Outline of problem: With care shifting to out of hospital it’s important to up skill
primary care in delivering correct treatment options when patients attend
surgeries. Patients attend GP surgeries when they have exacerbations of their
c-
o-
n-
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dition, which is an opportunity to assess their condition and refer onto
pulmonary rehabilitation or a more in depth review.
Assessment: Fragmentation in the National Health Services (NHS) results in
inconsistent treatment of patients with COPD. Currently GPs have to search
through the entire patient history to check for previous COPD care and must
look up guidelines separately. This is challenging in a 10-minute consultation.
Strategy: The secondary care COPD discharge bundle has delivered high value
care across the UK. This now needs to be delivered ‘downstream’ to primary
care to ensure best practice.
Measurement of improvement: The primary care bundle has helped 2 GP
practices deliver high quality care while also providing insight into that
patients COPD history over the last 12 months.
Effects of changes: Patients with COPD receive evidenced based care by GPs
using the bundle, including referral to pulmonary rehabilitation.
Lessons learnt: The template pops up at the end of the consultation when the
GP clicks on the prescription, however after consultation we realise this needs
to happen earlier in the consultation. Options are being explored for making
this still a reliable pop up.The bundle is neat and aligned to the clinical
guidelines for COPD, making it a useful tool for GPs practices to use.
Conﬂicts of interest: N/A.
Funding: Provided by the National Institute for Health Research (NIHR)
Collaboration and leadership in applied research and care Northwest London
(CLAHRC NWL).
Corresponding author: Dionne Matthew
Email address: d.matthew@imperial.ac.uk
55. Building a Theoretical Basis for Exploring the Role of South
Asian Culture on Asthma Self-Management Behaviour
Ahmed S1, Taylor SJC1, Pinnock H2, Steed L1
1Queen Mary University of London, UK, 2Centre for Primary Care and Public
Health, Asthma UK Centre for Applied Research
Background: Supported self-management improves asthma outcomes, but is
less effective in South Asian minority communities. Guidelines recommend
that interventions should be culturally tailored, but culture is not static as UK
born South Asians have greater cultural ﬂexibility compared to the ﬁrst
migrant generation, indicating differences in lifestyle and asthma needs.
Aim: To understand how to help people from different South Asian
subcultures/generations to look after their asthma better, we need to consider
subcultural heterogeneity and minority cultural shifts.
Method: We explored and mapped cultural shift theories in minority South
Asians relevant to developing an intervention.
Results: We identiﬁed two useful theoretical models:
(1) Berry’s1 model of acculturation (i.e. cultural changes inﬂuenced by coming
in to contact with another culture) suggests individuals adapt in one of four
ways: integration, assimilation, separation or marginalisation. In the context of
supported self-management, the mainstream culture can be viewed as the
degree of acculturation amongst healthcare professionals whose adaptation
reﬂects: multiculturalism, melting pot, segregation, exclusion, and their ability
to support various acculturated patients.
(2) Hall’s2 cultural hybridity theory suggests individuals with two or more cultures
tend to become bi-culturally competent and typically seek out what aspects of
their cultures are most signiﬁcant to them e.g. religion, health/illness beliefs.
Building on our theoretical understanding of culture as a shifting and
changing entity, our qualitative study will explore asthma self-management in
South Asians across different generations and healthcare professionals who
support these communities, to inform the development of a tailored
intervention which adapts to generational cultural shifts.
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56. Can we take adult asthma patients off the list if they don’t
come to clinic?
Goodwin D
GP, Shrewsbury, UK
Outline: Those diagnosed with asthma in adulthood are unlikely to “grow out
of it”. Once on this list, the practice has the task of regularly reviewing patients.
This can be onerous for practices and unwelcome by patients. When
I conducted a longitudinal audit of asthma exacerbations the longest interval
from last clinic attendance to onset of exacerbation was 13 years. Lack of
compliance/adherence was emerging as the most common cause of
exacerbations. Panhuysen et al. in 1997 suggested that 11% of adults may
no longer have asthma at a 25 year follow up, with earlier age of diagnosis,
milder disease and earlier therapeutic intervention being predictive of this
happening.
For every 10 patients on the asthma register a full review will take 15 hours
and several visits by each patient.We are probably not using our time most
efﬁciently in targeting the co-operative.
Assessment: Patients with no symptoms or no need for further medication (in
their belief) are less likely to attend review appointments.The enquiry into asthma
deaths showed that they can occur at any previous disease severity and age.
Strategy: Prioritise in this order: overuse of relief medication; exacerbations;
using medications without attending review; persistent non-attendance or not
using medications; recent review. Each should have spirometry and prescribe
peakﬂow meter if conﬁrmed asthma.
Effects of changes: Less waste of time and expertise.
Lessons learnt: If the original asthma diagnosis was made on secure grounds,
then it is probably safer to assign the patient to British Thoracic Society BTS/
SIGN step 1 with relief inhaler and conduct a telephone review.Pinnock et al.
(2005) have shown this to be preferred by patients for this severity and others
have shown to be more cost effective.
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57. Review of the use of high dose inhaled corticosteroids in
people with asthma aged 12 or over in primary care
Knowles V, Mackay R, Watts D
Guildford and Waverley (G&W) Clinical Commissioning Group (CCG), UK
Outline: Inhaled corticosteroids (ICS) are the ﬁrst choice preventer treatment
for people with asthma for achieving overall treatment goals. British Thoracic
Society BTS/SIGN guideline for the management of asthma recommends that
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Figure 1. Acculturation strategies in ethnocultural groups and the
larger society.1
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the dose of ICS should be titrated to the lowest dose at which effective control
of asthma is maintained to minimise side effects of ICS.
Outline of problem: Seretide (ﬂuticasone / salmeterol) is the most commonly
prescribed combination inhaler in G&W with the highest strength devices
being the most commonly prescribed doses accounting for 73% cost of all
respiratory prescribing.
Assessment: Guidelines recommend that reductions in ICS dose should be
considered every three months but often are not implemented leaving some
people over treated. QOF data across G&W identiﬁed 813 asthma patients
prescribed high dose ICS. 229 patients were excluded due to co-morbidities
leaving 584 patients suitable for review.
Strategy: Virtual clinics carried out to discuss case management and
patients invited in for review. Joint clinics carried out in practices where
learning needs had been identiﬁed. Algorithms circulated to support step-
down and action plans provided to support dose reduction with no loss of
asthma control.
Measurement of improvement: RCP three questions, peak ﬂow measurement,
short-acting beta agonist use and ICS inhaler concordance.
Effects of changes: 218 patients (43%) were deemed to have good asthma
control and treatment stepped down. 18 patients with poor asthma control
were referred to specialist clinic for review.
Lessons learnt: Lessons learnt: Asthma step-down is recommended but it is
often not implemented leaving some people over treated which was the case
locally.
Message for others: Consultant respiratory nurse support to primary care
enabled nurses to have more conﬁdence in reviewing asthma patients
enabling reduction of ICS without loss of asthma control.
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58. The Administration of Omalizumab in a Community Setting
Price K, Miles G, Miles J
BreathingSpace, Badesley Moor Lane, Rotherham. S. Yorks, UK
Aim: Omalizumab is licensed for the treatment of severe allergic asthma. It is
currently recommended for use in a hospital setting on account of the
potential of patients to suffer anaphylaxis following its administration.
BreathingSpace is a specialist community-based respiratory unit run by nurses
and supported by therapists and a visiting consultant physician once a week.
The nursing staff are trained in intermediate life support, including the
management of anaphylaxis and so this unit had the potential to provide
Omalizumab to patients in a community setting. We report the ﬁndings of our
experience with ﬁrst 20 patients receiving Omalizumab therapy at
BreathingSpace.
Method: Patients fulﬁlling the NICE and SIGN criteria for Omalizumab therapy
were assessed at BreathingSpace by the asthma specialist nurse. They
comprised a mixture of those patients currently already receiving Omalizumab
at the local hospital or nearby tertiary centre, and those for whom
Omalizumab had been recommended to commence as part of their ongoing
asthma treatment. Those patients receiving their ﬁrst injection were asked to
remain on site for 60 minutes whereas those receiving the second injection
onwards were allowed to leave immediately.
Results: A total of 22 patients (17 F Age range 22-63) were assessed at
BreathingSpace between March 2015 and April 2016. Of these 22 patients 11
were already on maintenance Omalizumab therapy (without complication)
and 11 were referred to commence treatment. 12 were receiving
monthly injections and 10 fortnightly injections. A total of 1378 injections
were given at BreathingSpace with no adverse reactions reported. In particular
no reactions were reported by the 11 patients initiated on Omalizumab
therapy.
In our hands Omalizumab is safe to administer in a community setting and
therefore follow up hospital appointments merely for the purpose of
Omalizumab administration are no longer required.
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59. Rotherham’s response to NRAD 2014
Price K, Miles J, Miles G
BreathingSpace, Badesley Moor Lane, Rotherham, South Yorks., S65 2QL, UK
Outline: Following the publication of the NRAD report in 2014 BreathingSpace
reallocated its existing resource in order to provide 17 hours of specialist
asthma liaison nurse time. We report on the characteristics of the patients
referred in the initial 9 months of the asthma liaison nurse role and compare to
those patients reported in NRAD.
Rotherham Foundation Trust did not have any specialist nurse post speciﬁcally
for patients with asthma at the time of the publication of the NRAD report.
Using this report as a lever we introduced an Asthma Liaison Nurse post
(17 hrs a week over 3 days) in March 2015 to enhance the care of patients with
difﬁcult to control asthma and provide both support for general practice
colleagues as well as ensuring the key recommendations from the NRAD
report were met (see Table 1). This was a limited resource and so we needed
to identify whether appropriate patients were being seen by our new
incumbent.
Strategy: The post holder made her details available in the A+E department,
Acute Admissions Ward and all other hospital Wards, encouraging referral
during admission for acute Asthma. In addition she has offered a service for
review of any difﬁcult asthmatic patients via direct referral from GPs, PNs or
other medical/nursing colleagues within the hospital.
Measurement of improvement: An increase in PAAP allocation from 4% to 96%
between March 2015 and April 2016. All health care professionals involved in
the care of patients with Asthma in Rotherham now have access to a Specialist
service for advice during admission and follow up after admission. All primary
care colleagues have access to advice for patients who are having frequent
exacerbations or are otherwise difﬁcult to manage.
Table 1.
Parameter NRAD Asthma Liaison Nurse
Prevalence (n= 196) Prevalence (n= 119)
Age 440 75% 74%
Sex F 59% 76%
Ethnicity White Caucasian 84% 92%
Lifelong Non-Smoker 52% 53%
Ex-smoker 25% 33%
Current Smoker 20% 14%
Anxiety/Depression 32% 32%
BMI o20 17% 3%
BMI 20-25 26% 25%
BMI 25-30 25% 17%
BMI 430 31% 56%
Step 1 BTS 9% 2%
Step 2-3 BTS 49% 52%
Step 4-5 BTS 42% 35%
Previous ICU admission 15% 8%
Personal Asthma Action Plan (PAAP) 9% 4%
BTS=British Thoracic Society.
[59]
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Lessons learnt: Greater engagement with the ED is required to ensure frequent
ED attenders who do not get admitted are not lost to follow up. A teaching
session on a regular basis has been established to address this issue. Issues
relating to excessive weight are prevalent in our asthma cohort and a more
effective interventional strategy is required.The case load of an asthma liaison
nurse in Rotherham reﬂects the patient population in NRAD and therefore has
the potential to address many of the issues identiﬁed in the NRAD report.
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60. Reducing unplanned care through CBT for people with
COPD
Lim KK, Bolton CE, Horrocks MD
Nottinghamshire Healthcare NHS Foundation Trust, UK
Outline: Evidence shows comorbidity between COPD and common mental
health problems (CMHPs) is common, and can lead to worse prognosis,
treatment non-compliance, increased admissions, and higher mortality.
Outline of problem: Within Nottingham West estimated prevalence levels of
COPD are higher than comparator Clinical Commissioning Groups (CCG).
Anxiety and depression are shown to effect more than 33% of people with
COPD. This comorbidity can cause problems with treatment engagement and
compliance.
Assessment: Cognitive Behavioural Psychotherapy (CBT) can provide a valuable
treatment adjunct targeting symptoms associated with CMHPs, to reduce
emotional distress, enhancing treatment engagement and increasing
psychological coping skills. Between 2013 and 2016, COPD patients with
comorbid CMHPs (n= 136) accessed CBT delivered by psychotherapists
working as integrated members of the community COPD service.
Measurement of improvement: (1) Patient self-reported outcome measures
used to record severity of psychological distress: (PHQ-9, GAD-7). (2) Service
utilisation tracked with the Client Service Receipt Inventory (CSRI). (3)
Estimated impact on service costs was made with reference to the Unit Costs
of Health and Social Care.
A total of 136 patients completed two or more CBT sessions. Signiﬁcant
improvement (decreased scores by 4 points or more) was reported, on PHQ-9
(n= 85, 62.5%) and GAD-7 (n= 82, 60%), reﬂecting reduced CMHP symptoms.
Using the CSRI to contrast service use 4 months pre-treatment and during
treatment, reductions were reported in acute admissions (13.25% ), A&E visits
(35.29%), Emergency Ambulances (23.53%), and emergency GP (51.06%),
providing estimated cost savings of £59,016.
Lessons learnt: Integrating CBT psychotherapists into community COPD
services can provide a valuable treatment adjunct.
Message for others: Providing CBT in COPD services, can contribute to
reductions in comorbid symptoms and service utilisation.
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61. Reaching the 'hard to reach' using an intensive approach
within a hospital Complex COPD outpatient clinic
Perry MJ
Leicester, UK
Outline: This presentation will outline the planning, preparation, treatment
methods and the subsequent successful outcomes that we have experienced
from supporting outpatient’s attending a complex COPD clinic one year on,
some of which are higher than our regular population of service users.
Outline of problem: Around thirty to forty percent of patients attending the
advanced COPD outpatient’s clinic at Glenﬁeld hospital continue to smoke,
despite the fact that stopping is the most effective method of slowing down
the progression of this disease. Smoking Cessation referral uptake, however,
has been historically poor; therefore a new approach to capturing this patient
group had to be implemented.
Assessment: Within secondary care we continuously strive to capture referrals,
search for new and innovative ways to engage with patients with long term
conditions, and aim to treat and improve our patients declining health.
Strategy: Though using an intensive approach, tackling patients with complex
conditions could have signiﬁcant impact on improving health amongst some
of our previously hard to reach population.
Measurement of improvement: I was invited to work alongside the Complex
COPD clinic to see if improvements could be made to the referral pathway,
outcome and relationship.
Effects of changes: All patients that attend the clinic and who smoke were
routinely seen, alongside the clinicians, by the specialist advisor who then
guides them through the various treatment options available to them. By
taking a pragmatic approach, we have eased the journey by taking away any
pressure to quit immediately and used a harm reduction approach with a
patient-led tailored programme motivating the patients to act straight away.
Lessons learnt: Patients with long term conditions who continue to smoke
should still be actively encouraged to stop or reduce their exposure to the
harms of tobacco by forming a non-judgemental relationship and providing
ongoing support for their nicotine dependency. Through providing a
dedicated service that is located directly alongside the clinicians within
outpatients, we are reaping the beneﬁts of a high quality specialised
intervention right at the point of heightened motivation amongst our
smoking population with substantial success.
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